Courses & outcomes
Course descriptions and learning outcomes.
Interim Stream Review · Prototype
Stream Overview
What does learning in this stream look like across the program and within each year?
This workspace moves from a high-level orientation to an interactive curriculum portrait and then to searchable source records, helping reviewers understand the stream across the program, examine year-specific evidence, and verify the records behind the summary.
Evidence at a Glance
What curriculum evidence am I reviewing?
Teaching & topics
Sessions, topics, types, duration, and instructional characteristics.
Assessment
Assessment structure and available descriptions.
High-Level Overview of Learning
What does learning look like in this stream?
Overall focus
The Practice Skills stream documents applied pharmaceutical calculations, prescription processing, the pharmacist patient‑care process, basic physical assessment, drug‑information retrieval, point‑of‑care tasks and professionalism across Years 1–3. Outcomes include knowledge, skills and attitudes tied to community and hospital practice contexts and simulated practice tasks.
Development across years
Documented emphasis shifts from Year 1 foundational calculation and processing skills toward Year 2 applied patient‑care activities, medication reconciliation and point‑of‑care diagnostics, and Year 3 advanced patient‑care implementation, teamwork, lab best practices and higher‑stakes observed assessments; delivery moves from lecture/lab mixes to paired lab/seminar active learning.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Practice Skills stream documents applied patient‑care competencies across Years 1–3, including pharmaceutical calculations and measurement, prescription receipt/checking/processing, the pharmacist patient‑care process (gathering/assessing/documenting information, identifying drug‑related problems, therapeutic decision‑making), patient education and monitoring, drug‑information retrieval, communication with patients and providers, basic physical assessment and device technique, point‑of‑care testing and injection/administration skills. Professionalism, reflective practice and teamwork are recurring features.
53Documented learning outcomes
134Documented topics
7AFPC roles represented
46CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
KSAs are skills‑dominant with numerous procedural and communication competencies; attitudes (professional behavior, initiative, reflection) are consistently recorded and knowledge items underpin applied tasks like calculations and standards.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 24
2024-2025n = 29
2023-2024n = 29
Year 2
2025-2026n = 16
2024-2025n = 15
2023-2024n = 13
Year 3
2025-2026n = 14
2024-2025n = 11
2023-2024n = 11
AFPC professional roles
AFPC mappings are concentrated in the Care Provider role with substantial Communicator and Professional mappings, documenting curricular emphasis on direct patient care activities, communication and professionalism.
- Care Provider
- Communicator
- Professional
- Collaborator
- Scholar
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
CCAPP curriculum topics
CCAPP mappings cluster in practice‑skills categories: patient and professional communications, patient assessment/pharmacotherapy work‑up, pharmacist patient‑care process, dispensing and monitoring — documenting emphasis on practical, workplace‑oriented tasks and clinical assessment.
- patient and professional communications
- patient assessment/pharmacotherapy work-up
- pharmacist patient care process
- professional learning and development
- monitoring & follow-up
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 98 | 2024-2025 n = 135 | 2023-2024 n = 138 |
|---|---|---|---|
| patient and professional communications | 67% | 65% | 55% |
| patient assessment/pharmacotherapy work-up | 59% | 56% | 45% |
| pharmacist patient care process | 32% | 25% | 37% |
| professional learning and development | 13% | 14% | 20% |
| monitoring & follow-up | 10% | 12% | 19% |
| dispensing and prescription processing | 26% | 21% | 19% |
| collaborative care and shared decision-making | 16% | 16% | 14% |
| drug information provision | 11% | 11% | 12% |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 5% | 14% | 11% |
| documentation of care | 14% | 14% | 10% |
| practical compounding | 25% | 12% | 10% |
| pharmacy law and regulatory issues | 9% | 13% | 10% |
| care plan development | 11% | 10% | 10% |
| administration of drugs by injection | 13% | 10% | 10% |
| ethical and professional standards of practice | 4% | 5% | 7% |
| physical assessment | 3% | 3% | 7% |
| diagnostic and point-of-care testing | 6% | 8% | 7% |
| infectious disease | — | 3% | 6% |
| professional identity formation | 3% | 3% | 6% |
| evidence-based decision making | 3% | 6% | 6% |
| best possible medication history and medication reconciliation | 7% | 6% | 4% |
| digital health | 3% | 3% | 4% |
| pharmacoeconomics | 1% | 4% | 4% |
| patient safety | 4% | 6% | 4% |
| sexual and reproductive health | 5% | 4% | 4% |
| substance use disorders, dependency, and addiction | 2% | 4% | 4% |
| cardiology | 4% | 6% | 3% |
| care plan implementation | 4% | 3% | 3% |
| cultural diversity | 2% | 3% | 3% |
| quality improvement | 2% | 3% | 3% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 2% | 3% | 3% |
| nutrition | 2% | 3% | 3% |
| nephrology | 2% | — | 3% |
| professional wellbeing | — | — | 3% |
| dermatology | — | — | 3% |
| patient self-care and management of minor ailments | 3% | 4% | 3% |
| health equity and social determinants of health | 2% | 3% | 3% |
| psychiatric and mental health | 2% | 3% | 3% |
| cultural safety, humility, and responsiveness | — | 3% | 3% |
| public health | — | 3% | 3% |
| neurology | — | 3% | 3% |
| oncology | — | 3% | 3% |
| critical appraisal of medical literature | — | 1% | 3% |
| immunology | — | — | 1% |
| medicinal chemistry | 1% | 1% | 1% |
| collection of patient data | — | 1% | 1% |
| endocrinology | 6% | 3% | — |
| toxicology | 5% | — | — |
| healthcare systems and health economics | 2% | — | — |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | — | — |
| virtual care provision | 2% | — | — |
| healthcare education | 2% | 2% | — |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Practice Skills shares documented learning with BASE in areas including patient and professional communication, patient assessment and pharmacotherapy work‑up, evidence appraisal/application, pharmacy law/regulatory topics, and professional development/leadership across Years 1–3. The overlap is evidenced by aligned course outcomes, session‑level topics, assessment weightings, and the provided framework mappings in the 2023–2024 documentation.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Practice Skills shares documented learning with Pharmaceutical Sciences across Years 1–3 in patient‑assessment and practice activities (monitoring & follow‑up, diagnostic testing, prescriptive decision‑making and compounding) that connect to Pharmaceutical Sciences instruction in pharmacology, pharmaceutics and toxicology. Course outcomes, session lists and CCAPP/AFPC mappings provided for the full cycle document these adjacent/overlapping topical areas across the three years.
Therapeutics
Therapeutic decision-making and clinical application
Practice Skills shares documented learning across Years 1–3 with Therapeutics in applied patient-care activities, including patient assessment/pharmacotherapy work‑up, documentation of care, monitoring and follow‑up, patient and professional communication, and elements of administration by injection. The packet evidence for the full cycle shows these topics are present in Practice Skills course outcomes, session topics and assessments alongside complementary Therapeutics coverage of condition‑specific therapeutic approaches and monitoring.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Instruction is organized around paired laboratory and seminar cycles that emphasize applied patient‑care skills. Students spend sustained lab time practicing the patient‑care process, technical prescription tasks and physical assessment, paired with short seminars to debrief and consolidate learning. Distinctive activities include extended skills labs (history taking, BPMH, point‑of‑care testing), simulated OSCE style assessments, interprofessional collaboration labs, peer feedback sessions, and focused communication and counselling practice.
Documented delivery mix
5Lecture
77Seminar
78Lab
4Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 69
2024-2025n = 58
2023-2024n = 60
Year 2
2025-2026n = 52
2024-2025n = 52
2023-2024n = 52
Year 3
2025-2026n = 45
2024-2025n = 52
2023-2024n = 52
How learning is assessed
Students are expected to demonstrate applied clinical skills, clinical reasoning, care planning, and professional behaviour. Assessment routinely elicits these performances through written care‑plan assignments, graded lab activities and quizzes that simulate clinical tasks, and mandatory professionalism checks. In later courses, performance assessments (OSCEs and practical stations) and structured reflections are used to capture hands‑on skills and judgement. Group work and peer evaluation document collaborative practice. The overall pattern emphasizes repeated applied tasks and performance assessments rather than purely objective testing.
Assessment pattern
12Assignment/written work
5Final exam
4Midterm exam
3Other exam/test
3Participation/professionalism
- Assignment/written work
- Final exam
- Midterm exam
- Other exam/test
- Participation/professionalism
- Other
Year 1
2025-2026n = 16
2024-2025n = 16
2023-2024n = 14
Year 2
2025-2026n = 9
2024-2025n = 16
2023-2024n = 9
Year 3
2025-2026n = 9
2024-2025n = 8
2023-2024n = 8
Overall focus
The Practice Skills stream emphasizes applied practice skills and professional behaviours: pharmaceutical calculations, the pharmacist patient‑care process, BPMH/medication reconciliation, point‑of‑care testing, injection administration and communication across Years 1–3. Outcomes are skills‑ and attitude‑oriented and include simulation, OSCE preparation and teamwork.
Development across years
Documented progression shows Year 1 focus on foundational calculations and dispensing tasks, Year 2 on applied patient‑care activities and diagnostic/point‑of‑care skills, and Year 3 on applied clinical decision making, prescriptive adaptation, injection administration and performance assessments (e.g., OSCE), with active‑learning paired lab/seminar formats throughout.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Practice Skills curriculum documents applied competencies across Years 1–3 with emphasis on pharmaceutical calculations, the pharmacist patient‑care process (assessment, prioritizing drug‑related problems, documentation and monitoring), therapeutic reasoning, drug‑information use, point‑of‑care testing and injection administration, and professionalism and reflective practice. Year 1 focuses on foundational tasks; Years 2–3 build toward advanced assessment, care‑plan development, prescriptive decision making and interprofessional teamwork.
55Documented learning outcomes
139Documented topics
7AFPC roles represented
44CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
KSAs are predominantly skills with strong practical competencies (calculations, assessment, documentation, injections) supported by explicit knowledge items and consistent attitudinal expectations for professionalism and reflection.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 24
2024-2025n = 29
2023-2024n = 29
Year 2
2025-2026n = 16
2024-2025n = 15
2023-2024n = 13
Year 3
2025-2026n = 14
2024-2025n = 11
2023-2024n = 11
AFPC professional roles
AFPC mappings are predominantly Care Provider with substantial Communicator representation and Professional mappings, documenting curriculum emphasis on direct patient care, communication, and professional accountability across the stream.
- Care Provider
- Communicator
- Professional
- Collaborator
- Health Advocate
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
CCAPP curriculum topics
CCAPP mappings concentrate on practice skills: patient and professional communications, patient assessment/pharmacotherapy work‑up, pharmacist patient‑care process, dispensing and monitoring & follow‑up — documenting applied workplace competencies for patient management.
- patient and professional communications
- patient assessment/pharmacotherapy work-up
- pharmacist patient care process
- dispensing and prescription processing
- collaborative care and shared decision-making
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 98 | 2024-2025 n = 135 | 2023-2024 n = 138 |
|---|---|---|---|
| patient and professional communications | 67% | 65% | 55% |
| patient assessment/pharmacotherapy work-up | 59% | 56% | 45% |
| pharmacist patient care process | 32% | 25% | 37% |
| dispensing and prescription processing | 26% | 21% | 19% |
| collaborative care and shared decision-making | 16% | 16% | 14% |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 5% | 14% | 11% |
| documentation of care | 14% | 14% | 10% |
| professional learning and development | 13% | 14% | 20% |
| pharmacy law and regulatory issues | 9% | 13% | 10% |
| monitoring & follow-up | 10% | 12% | 19% |
| practical compounding | 25% | 12% | 10% |
| drug information provision | 11% | 11% | 12% |
| care plan development | 11% | 10% | 10% |
| administration of drugs by injection | 13% | 10% | 10% |
| diagnostic and point-of-care testing | 6% | 8% | 7% |
| cardiology | 4% | 6% | 3% |
| best possible medication history and medication reconciliation | 7% | 6% | 4% |
| patient safety | 4% | 6% | 4% |
| evidence-based decision making | 3% | 6% | 6% |
| ethical and professional standards of practice | 4% | 5% | 7% |
| pharmacoeconomics | 1% | 4% | 4% |
| patient self-care and management of minor ailments | 3% | 4% | 3% |
| sexual and reproductive health | 5% | 4% | 4% |
| substance use disorders, dependency, and addiction | 2% | 4% | 4% |
| endocrinology | 6% | 3% | — |
| infectious disease | — | 3% | 6% |
| care plan implementation | 4% | 3% | 3% |
| cultural diversity | 2% | 3% | 3% |
| quality improvement | 2% | 3% | 3% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 2% | 3% | 3% |
| nutrition | 2% | 3% | 3% |
| physical assessment | 3% | 3% | 7% |
| professional identity formation | 3% | 3% | 6% |
| digital health | 3% | 3% | 4% |
| health equity and social determinants of health | 2% | 3% | 3% |
| psychiatric and mental health | 2% | 3% | 3% |
| cultural safety, humility, and responsiveness | — | 3% | 3% |
| public health | — | 3% | 3% |
| neurology | — | 3% | 3% |
| oncology | — | 3% | 3% |
| healthcare education | 2% | 2% | — |
| medicinal chemistry | 1% | 1% | 1% |
| collection of patient data | — | 1% | 1% |
| critical appraisal of medical literature | — | 1% | 3% |
| toxicology | 5% | — | — |
| nephrology | 2% | — | 3% |
| professional wellbeing | — | — | 3% |
| dermatology | — | — | 3% |
| healthcare systems and health economics | 2% | — | — |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | — | — |
| virtual care provision | 2% | — | — |
| immunology | — | — | 1% |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Overall (Years 1–3) Practice Skills shares documented curricular territory with BASE in communication, patient assessment and care planning, evidence appraisal and application, regulatory/jurisprudence topics, and leadership/management. The overlap is evidenced by aligned course outcomes, session‑level topic lists, assessment structures and framework mapping counts included in the 2024–2025 documentation.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Practice Skills shares documented learning with Pharmaceutical Sciences across Years 1–3 in patient assessment and applied practice activities (compounding, diagnostic/point‑of‑care testing, monitoring & follow‑up and prescriptive decision‑making) that connect to Pharmaceutical Sciences content in pharmaceutics, pharmacokinetics and toxicology. The supplied course outcomes, session lists and framework mappings for the cycle reflect these documented intersections.
Therapeutics
Therapeutic decision-making and clinical application
Across the 2024–25 cycle, Practice Skills documents applied competencies that share territory with Therapeutics, notably patient assessment and pharmacotherapy work‑up, documentation of care and care‑plan development/implementation, monitoring and follow‑up, communication skills, and some injection administration. The stream‑level course and session inventories show these practice activities recurrently across Years 1–3 alongside Therapeutics’ condition‑focused content.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
The stream is delivered predominantly face‑to‑face through integrated lab and seminar sequences that prioritize active learning. Students rotate through repeated multi‑hour lab experiences paired with 50‑minute seminars: labs for hands‑on practice of patient assessment, prescription processing and point‑of‑care testing; seminars for debrief, documentation and exam preparation. Distinctive activities across years include simulated community pharmacist days, peer‑led teaching, case‑based OSCE preparation and an injection authorization block in the later year.
Documented delivery mix
5Lecture
76Seminar
77Lab
4Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 69
2024-2025n = 58
2023-2024n = 60
Year 2
2025-2026n = 52
2024-2025n = 52
2023-2024n = 52
Year 3
2025-2026n = 45
2024-2025n = 52
2023-2024n = 52
How learning is assessed
Students are expected to perform clinical tasks, develop and document care plans, and demonstrate professional behaviours. Assessments characteristically combine written care plan assignments and lab activities/quizzes with an emphasis on staged, application‑based tasks. Professionalism metrics and critical reflections are regular features, and Year 3 performance is assessed through an OSCE and written stations to capture clinical interaction and decision making. Group tasks and integrated cases assess collaboration and applied judgment.
Assessment pattern
16Assignment/written work
6Final exam
5Midterm exam
4Participation/professionalism
3Other exam/test
- Assignment/written work
- Final exam
- Midterm exam
- Participation/professionalism
- Other exam/test
- Other
Year 1
2025-2026n = 16
2024-2025n = 16
2023-2024n = 14
Year 2
2025-2026n = 9
2024-2025n = 16
2023-2024n = 9
Year 3
2025-2026n = 9
2024-2025n = 8
2023-2024n = 8
Overall focus
The Practice Skills stream documents pharmaceutical calculations, clinical communication, prescription processing, the pharmacist patient‑care process, simulation/OSCE performance, point‑of‑care testing and professionalism across Years 1–3. Course outcomes include knowledge, skills and attitudes for community and clinical practice, with specific entries for injection technique and immunization consent in later courses.
Development across years
Documented progression moves from Year 1 calculation‑ and dispensing‑oriented outcomes to Year 2 applied patient‑care skills, BPMH/medication reconciliation and diagnostic reasoning, and Year 3 advanced integrative assessment, care‑planning, injection training and high‑stakes OSCEs. The packet consistently shows paired lab/seminar delivery and increasing performance‑based assessment in later years.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Practice Skills stream documents applied, workplace‑oriented competencies across seven courses spanning Years 1–3: pharmaceutical calculations and measurement, patient assessment and pharmacotherapy work‑ups, best‑possible medication histories and reconciliation, care‑plan development and implementation, injection technique and immunization consent, diagnostic and point‑of‑care testing, clinical documentation, evidence‑based drug information use, interprofessional communication and professionalism.
54Documented learning outcomes
156Documented topics
7AFPC roles represented
42CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
KSAs are strongly skills‑oriented with many procedural, assessment and communication tasks; knowledge items support calculation and standards, and attitudes focus on professional behaviour and reflective practice.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 24
2024-2025n = 29
2023-2024n = 29
Year 2
2025-2026n = 16
2024-2025n = 15
2023-2024n = 13
Year 3
2025-2026n = 14
2024-2025n = 11
2023-2024n = 11
AFPC professional roles
AFPC mappings predominantly map to Care Provider and Communicator roles, documenting curriculum emphasis on direct patient care activities, communication and professional responsibilities across practice settings.
- Care Provider
- Communicator
- Professional
- Collaborator
- Scholar
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
CCAPP curriculum topics
CCAPP mappings concentrate in practice‑skills categories: patient and professional communications, patient assessment/pharmacotherapy work‑up, pharmacist patient‑care process, dispensing, practical compounding and injection administration — documenting hands‑on clinical and medication‑management training.
- patient and professional communications
- patient assessment/pharmacotherapy work-up
- pharmacist patient care process
- dispensing and prescription processing
- practical compounding
- Other
Year 1
2025-2026n = 102
2024-2025n = 90
2023-2024n = 92
Year 2
2025-2026n = 63
2024-2025n = 82
2023-2024n = 89
Year 3
2025-2026n = 55
2024-2025n = 97
2023-2024n = 98
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 98 | 2024-2025 n = 135 | 2023-2024 n = 138 |
|---|---|---|---|
| patient and professional communications | 67% | 65% | 55% |
| patient assessment/pharmacotherapy work-up | 59% | 56% | 45% |
| pharmacist patient care process | 32% | 25% | 37% |
| dispensing and prescription processing | 26% | 21% | 19% |
| practical compounding | 25% | 12% | 10% |
| collaborative care and shared decision-making | 16% | 16% | 14% |
| documentation of care | 14% | 14% | 10% |
| administration of drugs by injection | 13% | 10% | 10% |
| professional learning and development | 13% | 14% | 20% |
| drug information provision | 11% | 11% | 12% |
| care plan development | 11% | 10% | 10% |
| monitoring & follow-up | 10% | 12% | 19% |
| pharmacy law and regulatory issues | 9% | 13% | 10% |
| best possible medication history and medication reconciliation | 7% | 6% | 4% |
| diagnostic and point-of-care testing | 6% | 8% | 7% |
| endocrinology | 6% | 3% | — |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 5% | 14% | 11% |
| sexual and reproductive health | 5% | 4% | 4% |
| toxicology | 5% | — | — |
| ethical and professional standards of practice | 4% | 5% | 7% |
| patient safety | 4% | 6% | 4% |
| cardiology | 4% | 6% | 3% |
| care plan implementation | 4% | 3% | 3% |
| physical assessment | 3% | 3% | 7% |
| professional identity formation | 3% | 3% | 6% |
| evidence-based decision making | 3% | 6% | 6% |
| digital health | 3% | 3% | 4% |
| patient self-care and management of minor ailments | 3% | 4% | 3% |
| substance use disorders, dependency, and addiction | 2% | 4% | 4% |
| health equity and social determinants of health | 2% | 3% | 3% |
| psychiatric and mental health | 2% | 3% | 3% |
| healthcare systems and health economics | 2% | — | — |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | — | — |
| virtual care provision | 2% | — | — |
| cultural diversity | 2% | 3% | 3% |
| quality improvement | 2% | 3% | 3% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 2% | 3% | 3% |
| nutrition | 2% | 3% | 3% |
| nephrology | 2% | — | 3% |
| healthcare education | 2% | 2% | — |
| pharmacoeconomics | 1% | 4% | 4% |
| medicinal chemistry | 1% | 1% | 1% |
| infectious disease | — | 3% | 6% |
| professional wellbeing | — | — | 3% |
| dermatology | — | — | 3% |
| cultural safety, humility, and responsiveness | — | 3% | 3% |
| public health | — | 3% | 3% |
| neurology | — | 3% | 3% |
| oncology | — | 3% | 3% |
| critical appraisal of medical literature | — | 1% | 3% |
| collection of patient data | — | 1% | 1% |
| immunology | — | — | 1% |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Overall (Years 1–3) Practice Skills shares documented content with BASE in communication and counselling, patient assessment/pharmacotherapy work‑up, evidence appraisal/application, regulatory/jurisprudence content, and leadership/advocacy topics. This overlap is supported by the course‑level outcomes, session topics, assessment structures and framework mappings included in the 2025–2026 evidence.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Practice Skills shares documented learning with Pharmaceutical Sciences across Years 1–3 in applied patient‑care activities (patient assessment/pharmacotherapy work‑up, compounding, point‑of‑care testing, monitoring and prescriptive decision‑making) that align to Pharmaceutical Sciences instruction in pharmacology, pharmaceutics and toxicology. The documented course outcomes, session lists and mapping compositions supplied for the cycle show these areas of intersection.
Therapeutics
Therapeutic decision-making and clinical application
Across the 2025–26 cycle, Practice Skills documents applied, assessment‑oriented competencies that share curricular territory with Therapeutics, including patient assessment and pharmacotherapy work‑up, documentation and care‑plan development, monitoring and follow‑up, communication, and administration of injections. Course portraits, session topics and assessment types indicate these practice‑skill activities recur across Years 1–3 alongside Therapeutics’ condition‑focused instruction and case work.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Delivery mixes in‑person labs and seminars with pre‑recorded lectures, asynchronous preparation and on‑campus assessments. Students alternate content lectures (including some recorded modules) with hands‑on lab practice, simulation or workshops, and culminate many courses with OSCE‑style final exams. Distinctive activities include asynchronous prescription‑processing practice, in‑person communication workshops, supervised OSCE/clinical exams, and repeated lab practice for point‑of‑care testing and injection skills.
Documented delivery mix
32Lecture
61Seminar
53Lab
20Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 69
2024-2025n = 58
2023-2024n = 60
Year 2
2025-2026n = 52
2024-2025n = 52
2023-2024n = 52
Year 3
2025-2026n = 45
2024-2025n = 52
2023-2024n = 52
How learning is assessed
Students are expected to show applied clinical competence, simulation‑based performance, accurate documentation and consistent professionalism. Assessment blends interactive OSCE stations (interactive and non‑interactive), frequent applied lab assignments and quizzes, staged group care‑planning tasks, and short reflective pieces. Professionalism is explicitly scored with small percentage deductions for infractions and may require accountability documentation. The structure often includes cumulative practical finals and specified re‑attempt or mastery expectations for key summative elements.
Assessment pattern
14Assignment/written work
6Final exam
6Participation/professionalism
4Quiz
2Midterm exam
- Assignment/written work
- Final exam
- Participation/professionalism
- Quiz
- Midterm exam
- Other
Year 1
2025-2026n = 16
2024-2025n = 16
2023-2024n = 14
Year 2
2025-2026n = 9
2024-2025n = 16
2023-2024n = 9
Year 3
2025-2026n = 9
2024-2025n = 8
2023-2024n = 8
Explore the Curriculum
What curriculum records sit behind this overview?
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 215 — PHARM 215 - Pharmaceutical Calculations | Y1 | Fall | 5 | 3 | 0 | Assignment/written work (4); Other exam/test (1) | — |
| PHARM 220 — PHARM 220 - Patient Care Skills 1 | Y1 | Fall | 0 | 10 | 12 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 223 — PHARM 223 - Patient Care Skills 2 | Y1 | Winter | 0 | 13 | 13 | Assignment/written work (1); Final exam (1); Midterm exam (1); Other/unspecified (1); Participation/professionalism (1) | — |
| PHARM 320 — PHARM 320 - Patient Care Skills 3 | Y2 | Fall | 0 | 13 | 13 | Assignment/written work (2); Final exam (1); Midterm exam (1) | — |
| PHARM 323 — PHARM 323 - Patient Care Skills 4 | Y2 | Winter | 0 | 13 | 13 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1) | — |
| PHARM 420 — PHARM 420 - Patient Care Skills 5 | Y3 | Fall | 0 | 12 | 13 | Assignment/written work (1); Final exam (1); Other exam/test (1); Quiz (1) | — |
| PHARM 423 — PHARM 423 - Patient Care Skills 6 | Y3 | Winter | 0 | 13 | 14 | Assignment/written work (2); OSCE (1); Other exam/test (1) | — |
Session Information
| PHARM 215 | Y1 | Fall | 2023-08-31 | Lecture | Section 1: Topics 1-3 | Introduction into Pharmacy Math/Math Fundamentals, Systems of Measure – Part 1, Systems of Measure – Part 2 | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-09-07 | Lecture | Section 2: Topics 4-8 | Rates, Ratios and Proportions, Dimensional Analysis & The Formula Method, Calculating Doses – Part 1, Calculating Doses – Part 2, Elements of a Prescription & Accuracy in Calculations | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-09-07 | Seminar/case session | Seminar 1 | Topics 1-8 | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-09-25 | Lecture | Section 3: Topics 9-11 | Pharmaceutical Measurement, Density & Specific Gravity, Manipulating Formulas | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-10-12 | Seminar/case session | Seminar 2 | Topics 9-11 | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-10-16 | Lecture | Section 4: Topics 12 & 13 | Percentage Strength, Altering Product Strength, Use of Stock Solutions & Problem Solving by Alligation | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2023-11-06 | Lecture | Section 5: Topics 14-16 | Isotonic Solutions, Electrolyte Solutions, Intravenous Infusions & Rate of Flow Calculations | Gillian Johnson, Nasim Sarrami (guest lecturer for Topic 14 (TBC) |
| PHARM 215 | Y1 | Fall | 2023-11-23 | Seminar/case session | Seminar 3 | Topics 12-16 will be reviewed | Gillian Johnson |
| PHARM 220 | Y1 | Fall | 2023-09-14 | Laboratory | Lab 1 - Orientation | Lab orientation, team orientation, community pharmacy orientation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-09-14 | Seminar/case session | Seminar 1 - Introduction | Course introduction / expectations, professionalism, patient care process | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-09-21 | Laboratory | Lab 2 - Patient care process - Gathering information | Patient care process (gathering information), peer feedback, patient experience | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-09-21 | Seminar/case session | Sem 2 - Peer feedback process | Patient care process, peer feedback process, abbreviations in practice | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-09-28 | Laboratory | Lab 3 - Patient Interview / Information system training | Patient interview, training on information management system | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-09-28 | Seminar/case session | Sem 3 - Information management system | Debrief lab 2. Introduction to information management system | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-05 | Laboratory | Lab 4 - Documenting information / Receipt of a prescription | Patient care process (gathering and documenting information), receipt of a prescription, reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-05 | Seminar/case session | Sem 4 - Personal Reflection | Personal reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-12 | Laboratory | Lab 5 - Legal Assessment of a Prescription | Patient care process (gathering and documenting information), receipt of a prescription, assessment of a prescription (legal), verbal orders, reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-12 | Seminar/case session | Sem 5 - Assessment with Receipt of a Prescription | Debrief lab 4, receipt of a verbal prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-19 | Laboratory | Lab 6 - Assessing Prescription Appropriateness | Patient care process (assessing indication, effectiveness, safety, adherence), prescription processing / preparation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-19 | Seminar/case session | Sem 6 - Patient Centred Communication | Debrief lab 5, dispensing best practices | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-26 | Laboratory | Lab 7 - Assessing Appropriateness | Patient care process (refill medication), focused patient history, information only prescriptions | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-10-26 | Midterm exam | Sem 7 - Midterm Preparation | Debrief lab 6 and midpoint skills assessment preparation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-02 | Midterm exam | Lab 8 - Midterm Exam | Midterm exam | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-02 | Midterm exam | Sem 8 - Midterm Exam | Midterm Exam | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-09 | Laboratory | Lab 9 - Drug Information Inquiry | Drug information inquiry (receipt of request), written and verbal responses to answer a drug information inquiries, Netcare introduction | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-09 | Seminar/case session | Sem 9 - Drug Information Resources | Debrief lab 7, drug information resources when assessing a prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-16 | Laboratory | Lab 10 - Best Possible Medication History | Best possible medication history, refills / ongoing therapy, managing drug related problems | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-16 | Seminar/case session | Sem 10 - Best Possible Medication History | Debrief lab 9 and best possible medication history, Drug related problems | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-23 | Laboratory | Lab 11 - Prescription Appropriateness / Documentation / Prescription Pricing | Application of Alberta's prescription pricing model, Managing drug related problems, transfer of a prescription, Patient care process (accept / assess / document), prescription preparation and checking | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-23 | Seminar/case session | Sem 11 - Prescription Pricing / Documentation | Debrief lab 10, prescription pricing | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-30 | Laboratory | Lab 12 - Patient Care Process - Patient Cues - Pricing | Apply prescription pricing, managing drug related problems, Application of patient care process, Transfer of a prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-11-30 | Seminar/case session | Sem 12 - Prescription Pricing and Medication Adherence | Debrief lab 11, patient centred communication, scope of practice (pharmacists and pharmacy technicians), NOD / SBAR | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-12-07 | Laboratory | Lab 13 - Emotional Patients | Patient care process with an emotional (angry) patient, Complete a simulated “day in the life of a community pharmacist” | D. Barnes |
| PHARM 220 | Y1 | Fall | 2023-12-07 | Final exam | Sem 13 - Final Exam Preparation | Final exam orientation | D. Barnes |
| PHARM 223 | Y1 | Winter | 2024-01-11 | Laboratory | Lab 1 | Insurance Activities, Technical Checking, Patient Interactions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-01-11 | Seminar/case session | Seminar 1 | Course introduction/expectations, Review of identification, classification and documentation of drug-related problems (DRPs), Assessing drug theapy (IESA), Communicating Problems to Patients | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-01-18 | Laboratory | Lab 2 | Patient care process (refill monitoring/assessment), Patient education (eye and ear preparations), Drug benefit insurance, Drug use process (prescription checking) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-01-18 | Seminar/case session | Seminar 2 | Debrief of Lab 1, Lab 2 Preparation, Refill monitoring/assessment | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-01-25 | Laboratory | Lab 3 | Patient care process (minor ailments; database and assessment) [Focus: Eye/Ear], Mapping out recommended plan, Documentation, Patient education (rectal preparations), Assess (legal) and process controlled/targeted drug prescriptions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-01-25 | Seminar/case session | Seminar 3 | Debrief Lab 2, Lab 3 Preparation, Minor ailment assessment, Incorporating plan into the patient care process | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-01 | Laboratory | Lab 4 | Patient care process (minor ailments; database, assessment, plan) [Focus: GI], Documentation, Drug information, Patient education (lice and warts preparations), Assessing drug interactions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-01 | Seminar/case session | Seminar 4 | Debrief Lab 3, Lab 4 Preparation, Drug interactions, Incorporating plan into the patient care process | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-08 | Laboratory | Lab 5 | Physical examination of the skin, Patient education (epi-pen and related devices), Apply principles of medicinal chemistry to allergy assessment , Adverse drug reaction assessment and reporting | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-08 | Seminar/case session | Seminar 5 | Debrief Lab 4, Lab 5 Preparation, Principles of physical assessment | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-15 | Laboratory | Lab 6 | Patient care process (minor ailments; database, assessment, plan) [Focus: Dermatology], Prescription intake for pharmaceutics activity, Patient education (dandruff and acne preparations), Drug information, Assess (legal) and process narcotic/controlled drug and verbal prescriptions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-15 | Seminar/case session | Seminar 6 | Debrief Lab 5, Lab 6 Preparation | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-29 | Laboratory | Lab 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-02-29 | Seminar/case session | Seminar 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-07 | Laboratory | Lab 8 | Patient care process (minor ailment; database, assessment, plan) [Focus: Dermatology], Patient education (vaginal and nasal preparations), Health literacy, Escape room | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-07 | Seminar/case session | Seminar 8 | Lab 8 Preparation, Communicating with other healthcare providers, Debrief midpoint skills assessment (Lab 7) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-14 | Laboratory | Lab 9 | Patient care process (minor ailment; database, assessment, plan) [Focus: Cough & Cold/Seasonal Allergies], Counseling on compounded product from pharmaceutics lab, Patient education (inhalers, peak flow meter, spacers), Peer teaching plan | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-14 | Seminar/case session | Seminar 9 | Debrief Lab 8, Lab 9 Preparation | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-21 | Laboratory | Lab 10 | Pharmacy-Physical Therapy (PT) Collaborative Lab, Interprofessional collaboration and education, Physical assessment (pulmonary) , Medical terminology and top 100 drugs assessment | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-21 | Seminar/case session | Seminar 10 | Debrief Lab 9, Lab 10 Preparation (Pharmacy/PT joint lab) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-28 | Laboratory | Lab 11 | Incorporating clinical decision-making into patient care process [Focus: Asthma], Scope of practice (adapt, extend, emergency prescribe, refer), Medication incidents, How to pick an inhaler (considerations for special populations), Assess (legal) and process TPP prescriptions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-03-28 | Seminar/case session | Seminar 11 | Debrief Lab 10, Lab 11 Preparation , Scope of practice (extend, adapt, emergency prescribe) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-04-04 | Laboratory | Lab 12 | Incorporating clinical decision-making into patient care process [Focus: COPD], Scope of practice (adapt, extend, emergency prescribe, refer), Documentation, Patient education (nicotine replacement products- patches, gum, inhalers), Drug use process (prescription transfers), Evidence-based clinical practice | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-04-04 | Seminar/case session | Seminar 12 | Debrief Lab 11, Lab 12 Preparation , Clinical decision-making | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-04-11 | Laboratory | Lab 13 | Day in a Life of a Pharmacist, Patient Education (NRT), Create Your Own Simulation | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2024-04-11 | Seminar/case session | Seminar 13 | Debrief Lab 12, Lab 13 Preparation, Final Exam Preparation | D. Moulton/E. Leoni |
| PHARM 320 | Y2 | Fall | 2023-09-05 | Laboratory | Lab 1 | Team Building, Clinical prescription checking, aEHR orientation | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-05 | Seminar/case session | Seminar 1 | Course introduction, Reflective Practice, Clinical prescription checking | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-12 | Laboratory | Lab 2 | BPMH Practice, Complex Case #1, Writing DRP statements | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-12 | Seminar/case session | Seminar 2 | Medication Reconciliation, Introduction to integrated cases | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-19 | Laboratory | Lab 3 | IV Drug Info & Administration, BPMH LF Interaction | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-19 | Seminar/case session | Seminar 3 | Introduction to hospital pharmacy practice | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-26 | Laboratory | Lab 4 | Case Presentations, Assessing and managing electrolyte disturbances | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-09-26 | Seminar/case session | Seminar 4 | Case Presentations, Assessing and managing electrolyte disturbances | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-03 | Laboratory | Lab 5 | Hospital discharge, Ethics, Assessing adherence | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-03 | Seminar/case session | Seminar 5 | Hospital discharge, Ethics, Assessing adherence | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-17 | Laboratory | Lab 6 | Complex Case #2, Allergy assessment | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-17 | Seminar/case session | Seminar 6 | Practical application of drug info skills, Allergy assessment | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-23 | Laboratory | Lab 7 | MIDTERM EXAM (interactive station) | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-23 | Seminar/case session | Seminar 7 | Midterm Preparation | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-24 | Laboratory | Lab 8 | LUTS Lab: Home health care & Incontinence supplies | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-24 | Seminar/case session | Seminar 8 | MIDTERM EXAM (written) | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-31 | Laboratory | Lab 9 | PCP: Developing goals & alternatives, PCP: Writing a monitoring and follow-up plan | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-10-31 | Seminar/case session | Seminar 9 | PCP: Developing goals & alternatives, PCP: Writing a monitoring & follow-up plan | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-07 | Laboratory | Lab 10 | Point of care testing, Medical devices in diabetes care | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-07 | Seminar/case session | Seminar 10 | Integrated case workshop, Prioritizing DRPs | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-21 | Laboratory | Lab 11 | Introduction to physical exam, Drug device counselling | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-21 | Seminar/case session | Seminar 11 | Introduction to physical exam, Drug device counselling | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-28 | Laboratory | Lab 12 | Assessment and management of drug interactions | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-11-28 | Seminar/case session | Seminar 12 | Assessment and management of drug interactions | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-12-05 | Laboratory | Lab 13 | Review lab | Tate/Moulton |
| PHARM 320 | Y2 | Fall | 2023-12-05 | Seminar/case session | Seminar 13 | Final exam preparation, Review | Tate/Moulton |
| PHARM 323 | Y2 | Winter | 2024-01-09 | Laboratory | Lab 1 | Introduction, Using interpreters in patient care, Medication-taking tools & technology for people with disabilities | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-09 | Seminar/case session | Seminar 1 | Introduction, Using interpreters in patient care, Medication-taking tools & technology for people with disabilities | L.Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-16 | Laboratory | Lab 2 | Documentation, BP log assessment, GI Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-16 | Seminar/case session | Seminar 2 | Documentation, BP log assessment, GI Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-23 | Laboratory | Lab 3 | Ethics, Point-of-care testing | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-23 | Seminar/case session | Seminar 3 | Ethics, Point-of-care testing | L.Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-30 | Laboratory | Lab 4 | Scope of Practice, ID Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-01-30 | Seminar/case session | Seminar 4 | Scope of Practice, ID Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-06 | Laboratory | Lab 5 | Integrated Case 1, Heart failure cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-06 | Seminar/case session | Seminar 5 | Integrated Case 1, Heart failure cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-13 | Laboratory | Lab 6 | Monitoring and Follow up, ID Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-13 | Seminar/case session | Seminar 6 | Monitoring and Follow up, ID Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-27 | Laboratory | Lab 7 | MIDTERM | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-02-27 | Seminar/case session | Seminar 7 | MIDTERM | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-05 | Laboratory | Lab 8 | Shared-decision making, Dysphagia and medication administration | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-05 | Seminar/case session | Seminar 8 | Shared-decision making, Dysphagia and medication administration | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-12 | Laboratory | Lab 9 | A day-in-the life of a hospital pharmacist, Dealing with death & dying | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-12 | Seminar/case session | Seminar 9 | A day-in-the life of a hospital pharmacist, Dealing with death & dying | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-19 | Laboratory | Lab 10 | Integrated Case 2, TDM, Nutrition Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-19 | Seminar/case session | Seminar 10 | Integrated Case 2, Therapeutic drug monitoring, Vitamin Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-26 | Laboratory | Lab 11 | Hospital Discharge, Ophthalmology Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-03-26 | Seminar/case session | Seminar 11 | Hospital Discharge, Ophthalmology Cases | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-04-02 | Laboratory | Lab 12 | Root Cause Analysis, Learning Plans, Discharge Counselling | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-04-02 | Seminar/case session | Seminar 12 | Root Cause Analysis, Learning Plans, Discharge Counselling | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-04-09 | Laboratory | Lab 13 | Dermatology cases, Discharge counselling | L. Tate, L. Torok-Both |
| PHARM 323 | Y2 | Winter | 2024-04-09 | Seminar/case session | Seminar 13 | Dermatology cases, Discharge counselling | L. Tate, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-06 | Laboratory | Lab 1 - Pharmacist scope of practice, applying the patient care process | Pharmacists scope of practice: Verbal Prescriptions Patient Interaction: Applying the patient care process Decision making Implementing a monitoring and follow up plan | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-06 | Seminar/case session | Seminar 1 - Introduction & Foundations | Applying the patient care process, Pharmacists scope of practice, Decision making, Implementing a monitoring and follow up plan | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-13 | Laboratory | Lab 2 - HCM Part 1 | Providing person-centred care using Health Change Methodology: (Virtual online over 2 weeks) Chronic disease management Assessing readiness, importance, confidence and knowledge Understanding barriers to action and facilitators for change | R. Breault |
| PHARM 420 | Y3 | Fall | 2023-09-20 | Laboratory | Lab 3 - Care plan #1 | Providing person-centred care using Health Change Methodology: (Virtual online over 2 weeks) Chronic disease management Assessing readiness, importance, confidence and knowledge Understanding barriers to action and facilitators for change | R. Breault, L. Torok-Both, M. MacDonald |
| PHARM 420 | Y3 | Fall | 2023-09-20 | Seminar/case session | Seminar 3 - Care Plan #1 | Seminar 3 - Care Plan #1 | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-27 | Laboratory | Lab 4 - HCM Part 2 | Patient Interactions: applying person-centered care skills (HCM) - Patient assessment (focus on Diabetes and Pain) Utilizing drug information skills Drug use process and applying standards of practice Assessing patients for deprescribing | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-27 | Seminar/case session | Seminar 4 - HCM Part 2 | Chronic disease management, Person-centred care, Applying HealthChange Methodology, Assessing readiness, importance, confidence and knowledge, Understanding barriers to action and facilitators for change | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-04 | Laboratory | Lab 5 - Opioid Prescription Assessment | Lab 5 - Opioid Prescription Assessment | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-04 | Seminar/case session | Seminar 5 - Opioid Prescription Assessment | Drug Use Process and applying standards of practice to opioid prescriptions. Conducting an assessment of opioid prescriptions. | R. Breault, L-Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-11 | Laboratory | Lab 6 - Focus: Women's Health | Patient care: Women’s Health Graded patient interaction 2.5 % Drug use process and applying pharmacist standards of practice Applying critical appraisal skills to clinical decision making Minor ailments | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-11 | Seminar/case session | Seminar 6 - Focus: Women's Health | Drug use process and applying pharmacist standards of practice Applying critical appraisal skills to clinical decision making Minor ailments, Women's health, Evidence Based Medicine | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-25 | Laboratory | Lab 7 - Empathy, Patient Counselling (Oncology Focus) | Lab 7 - Empathy, Patient Counselling (Oncology Focus) | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-25 | Seminar/case session | Seminar 7 - Empathy/communication | Empathetic communication | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-01 | Laboratory | Lab 8 - Empathy, Palliative Care, Deprescribing | Communicating with patients who are emotionally upset (patient diagnosed with cancer) Applying appropriate standards for the handling of oral cytotoxic drugs | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-01 | Seminar/case session | Seminar 8 - Empathetic Communication | Patient communication in complex scenarios (patients who are dying), Communicating with palliative care patients. Emapathy, Communicating with patients who are emotionally upset (patient diagnosed with cancer) Applying appropriate standards for the handling of oral cytotoxic drugs | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-08 | Laboratory | Lab 9 - Social Determinants of Health, Drug Information, SBAR Practice | Social Determinants of Health, Drug Information and SBAR Practice | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-08 | Seminar/case session | Seminar 9 - Social Determinants of Health | Social Determinants of Health | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-15 | Laboratory | Lab 10 - Neurology Focus, Care Plan #2, Minor Ailments | Scope of practice, ethics, remuneration. Clinical assessment of drug-drug interactions Patient assessment and clinical decision making Patient interaction Neurology focus: Graded 2.5% | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-15 | Seminar/case session | Seminar 10 - Neurology Focus, Care plan #2 | Scope of practice, ethics, remuneration. Clinical assessment of drug-drug interactions Patient assessment and clinical decision making Patient interaction Neurology | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-22 | Seminar/case session | Seminar 11 - Mental Health Focus, Patient Counseling, Documentation | Patient communication in complex scenarios (mental health) Patient assessment (mental health) Applying principles of pharmacology to psychotropic drugs | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-23 | Laboratory | Lab 11 - Mental Health Focus, Patient Counselling, Documentation | Patient communication in complex scenarios (mental health) Patient assessment (mental health) Applying principles of pharmacology to psychotropic drugs | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-29 | Laboratory | Lab 12 - Substance Use Disorders, Vulnerable Populations | Providing care for vulnerable patients Patient communication in complex scenarios (substance use disorders) Naloxone training/Harm Reduction | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-29 | Seminar/case session | Seminar 12 - Substance Use Disorder, Vulnerable populations | Providing care for vulnerable patients, Patient communication in complex scenarios (substance use disorders), Naloxone training/Harm Reduction | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-12-06 | Laboratory | Lab 13 - Documentation. Course Wrap up | Shared Care plans Course Evaluation Final Exam information | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-12-06 | Seminar/case session | Seminar 13 - Written Assessment | Seminar 13 - Written Assessment | R. Breault, L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-10 | Laboratory | Lab 1 - Introduction | course Introduction, patient counselling, scope of Practice | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-10 | Seminar/case session | Sem 1 - Introduction | Course Introduction, Patient counselling, Scope of Practice | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-17 | Laboratory | Lab 2 - Patient Consent | Patient consent | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-17 | Seminar/case session | Sem 2 - Patient Consent | Patient consent, Ambulatory Care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-24 | Laboratory | Lab 3 - Injection training | Injection training | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-24 | Seminar/case session | Sem 3 - Injection training | Injection training | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-26 | Laboratory | Injection Authorization | Injections | — |
| PHARM 423 | Y3 | Winter | 2024-01-31 | Laboratory | Lab 4 - Pharmacists in Emergencies | Disaster planning, Providng care in emergencies, Emergency prescribing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-31 | Seminar/case session | Sem 4 - Pharmacists in Emergencies | Disaster planning, Providng care in emergencies, Emergency prescribing | K. Watson |
| PHARM 423 | Y3 | Winter | 2024-02-07 | Laboratory | Lab 5 - Discrimination, racism and bias in healthcare | Emergency care, Discrimination and racism | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-07 | Seminar/case session | Sem 5 - Discrimination, racism and bias in healthcare | Emergency care, Discrimination and racism | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-14 | Laboratory | Lab 6 - Inclusivity in Care of SOGIE clients | Reproductive health, PrEP, Care of SOGIE clients | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-14 | Seminar/case session | Sem 6 - Inclusivity in the care of SOGIE clients | Reproductive health, PrEP, Care of SOGIE clients | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-28 | Laboratory | Lab 7 - Deprescribing | Deprescribing, Medication management, Geriatric care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-28 | Seminar/case session | Sem 7 - Deprescribing | Deprescribing, Medication management, Geriatric care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-06 | Laboratory | Lab 8 - Death and Dying | Death and Dying, Ambiguous situations | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-06 | Seminar/case session | Sem 8 - Death and Dying | Death and Dying | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-13 | Laboratory | Lab 9 - Ambiguity in CDM & Ambulatory Assistive Devices | Ambulatory Assistive Devices, Elder Care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-13 | Seminar/case session | Sem 9 -Ambiguity in CDM | Ambiguity in decision making | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-20 | Laboratory | Lab 10 - Sexual Health | Sexual histories, STBBIs, Point of care testing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-20 | Seminar/case session | Sem 10 - Sexual Health | Sexual histories, STBBIs, Point of care testing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-27 | Laboratory | Lab 11 - Providing feedback | Feedback to other students | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-27 | Seminar/case session | Sem 11 - Providing feedback | Feedback to other students, Patient counselling | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-03 | Laboratory | Lab 12 - Travel Health | Travel health, Difficult discussions with providers | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-03 | Seminar/case session | Sem 12 - Travel Health | Travel health, Difficult discussions with prescribers | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-10 | Laboratory | Lab 13 - Review Lab | Semester Review, Transplant, Create your own case | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-10 | Seminar/case session | Sem 13 - Written Assessment | Written assessment | D. Barnes & L. Torok-Both |
Assessment Information
| PHARM 215 | Y1 | Assignment 1 | Assignment/written work | 20% | — |
| PHARM 215 | Y1 | Assignment 2 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Assignment 3 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Assignment 4 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Comprehensive Module Assessment | Other exam/test | 50% | — |
| PHARM 220 | Y1 | Final Exam (40%) | Final exam | 40% | — |
| PHARM 220 | Y1 | Midterm Exam (25%) | Midterm exam | 25% | — |
| PHARM 220 | Y1 | Professionalism (5%) | Participation/professionalism | 5% | — |
| PHARM 220 | Y1 | Lab Assignments and Quizzes (30%) | Quiz | 30% | — |
| PHARM 223 | Y1 | Lab Assignments | Assignment/written work | 30% | — |
| PHARM 223 | Y1 | Final Exam | Final exam | 35% | — |
| PHARM 223 | Y1 | Midterm Exam | Midterm exam | 25% | — |
| PHARM 223 | Y1 | Medical Terminology | Other/unspecified | 5% | — |
| PHARM 223 | Y1 | Professionalism | Participation/professionalism | 5% | — |
| PHARM 320 | Y2 | Integrated Care Plan | Assignment/written work | 10% | — |
| PHARM 320 | Y2 | Lab Assignments | Assignment/written work | 30% | — |
| PHARM 320 | Y2 | Final | Final exam | 30% | — |
| PHARM 320 | Y2 | Midterm | Midterm exam | 30% | — |
| PHARM 323 | Y2 | Integrated Cases | Assignment/written work | 10% | — |
| PHARM 323 | Y2 | Lab Assignments | Assignment/written work | 25% | — |
| PHARM 323 | Y2 | Final Exam | Final exam | 35% | — |
| PHARM 323 | Y2 | Midterm | Midterm exam | 25% | — |
| PHARM 323 | Y2 | Professionalism | Participation/professionalism | 5% | — |
| PHARM 420 | Y3 | Care Plan Assignments | Assignment/written work | 16% | — |
| PHARM 420 | Y3 | Final | Final exam | 40% | — |
| PHARM 420 | Y3 | Written Assessment | Other exam/test | 20% | — |
| PHARM 420 | Y3 | Lab Assignments and Quizzes | Quiz | 24% | — |
| PHARM 423 | Y3 | Lab Assignments (30%) | Assignment/written work | 30% | — |
| PHARM 423 | Y3 | Reflection (10%) | Assignment/written work | 10% | — |
| PHARM 423 | Y3 | OSCE (40%) | OSCE | 40% | — |
| PHARM 423 | Y3 | Written stations 20% | Other exam/test | 20% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 215 — PHARM 215 - Pharmaceutical Calculations | Y1 | Fall | 5 | 3 | 0 | Assignment/written work (4); Other exam/test (1) | — |
| PHARM 220 — PHARM 220 - Patient Care Skills 1 | Y1 | Fall | 0 | 10 | 12 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 223 — PHARM 223 - Patient Care Skills 2 | Y1 | Winter | 0 | 12 | 12 | Assignment/written work (2); Final exam (1); Midterm exam (1); Other/unspecified (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 320 — PHARM 320 - Patient Care Skills 3 | Y2 | Fall | 0 | 13 | 13 | Assignment/written work (5); Final exam (1); Midterm exam (1); Other/unspecified (1); Participation/professionalism (1) | — |
| PHARM 323 — PHARM 323 - Patient Care Skills 4 | Y2 | Winter | 0 | 13 | 13 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1) | — |
| PHARM 420 — PHARM 420 - Patient Care Skills 5 | Y3 | Fall | 0 | 12 | 13 | Assignment/written work (1); Final exam (1); Other exam/test (1); Quiz (1) | — |
| PHARM 423 — PHARM 423 - Patient Care Skills 6 | Y3 | Winter | 0 | 13 | 14 | Assignment/written work (2); OSCE (1); Other exam/test (1) | — |
Session Information
| PHARM 215 | Y1 | Fall | 2024-08-23 | Lecture | Section 1: Topics 1-4 | Introduction into Pharmacy Math/Math Fundamentals, Precision and Accuracy in Calculations, Systems of Measure & Conversions in Pharmacy, Interpreting the Prescription | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-08-23 | Lecture | Section 2: Topics 5-8 | Rates, Ratios and Proportions, Dimensional Analysis & The Formula Method, Calculating Doses – Part 1, Calculating Doses – Part 2, Elements of a Prescription & Accuracy in Calculations | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-09-05 | Seminar/case session | Seminar 1 | Topics 1-8 | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-09-30 | Lecture | Section 3: Topics 9-11 | Pharmaceutical Measurement, Density & Specific Gravity, Manipulating Formulas | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-10-10 | Seminar/case session | Seminar 2 | Topics 9-11, Topics 1-8 | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-10-14 | Lecture | Section 4: Topics 12 & 13 | Percentage Strength, Altering Product Strength, Use of Stock Solutions & Problem Solving by Alligation | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-11-04 | Lecture | Section 5: Topics 14-16 | Isotonic Solutions, Electrolyte Solutions, Intravenous Infusions & Rate of Flow Calculations | Gillian Johnson |
| PHARM 215 | Y1 | Fall | 2024-11-21 | Seminar/case session | Seminar 3 | All topics | Gillian Johnson |
| PHARM 220 | Y1 | Fall | 2024-09-12 | Laboratory | Lab 1 - Orientation | Lab orientation, team orientation, community pharmacy orientation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-09-12 | Seminar/case session | Seminar 1 - Introduction | Course introduction / expectations, professionalism, patient care process | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-09-19 | Laboratory | Lab 2 - Patient care process - Gathering information | Patient care process (gathering information), peer feedback, patient experience | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-09-19 | Seminar/case session | Sem 2 - Peer feedback process | Patient care process, peer feedback process, abbreviations in practice | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-09-26 | Laboratory | Lab 3 - Patient Interview / Information system training | Patient interview, training on information management system | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-09-26 | Seminar/case session | Sem 3 - Information management system | Debrief lab 2. Introduction to information management system | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-03 | Laboratory | Lab 4 - Documenting information / Receipt of a prescription | Patient care process (gathering and documenting information), receipt of a prescription, reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-03 | Seminar/case session | Sem 4 - Personal Reflection | Personal reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-10 | Laboratory | Lab 5 - Legal Assessment of a Prescription | Patient care process (gathering and documenting information), receipt of a prescription, assessment of a prescription (legal), verbal orders, reflection | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-10 | Seminar/case session | Sem 5 - Assessment with Receipt of a Prescription | Debrief lab 4, receipt of a verbal prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-17 | Laboratory | Lab 6 - Assessing Prescription Appropriateness | Patient care process (assessing indication, effectiveness, safety, adherence), prescription processing / preparation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-17 | Seminar/case session | Sem 6 - Patient Centred Communication | Debrief lab 5, dispensing best practices | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-24 | Laboratory | Lab 7 - Assessing Appropriateness | Patient care process (refill medication), focused patient history, information only prescriptions | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-24 | Midterm exam | Sem 7 - Midterm Preparation | Debrief lab 6 and midpoint skills assessment preparation | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-31 | Midterm exam | Lab 8 - Midterm Exam | Midterm exam | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-10-31 | Midterm exam | Sem 8 - Midterm Exam | Midterm Exam | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-07 | Laboratory | Lab 9 - Drug Information Inquiry | Drug information inquiry (receipt of request), written and verbal responses to answer a drug information inquiries, Netcare introduction | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-07 | Seminar/case session | Sem 9 - Drug Information Resources | Debrief lab 7, drug information resources when assessing a prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-14 | Laboratory | Lab 10 - Best Possible Medication History | Best possible medication history, refills / ongoing therapy, managing drug related problems | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-14 | Seminar/case session | Sem 10 - Best Possible Medication History | Debrief lab 9 and best possible medication history, Drug related problems | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-21 | Laboratory | Lab 11 - Prescription Appropriateness / Documentation / Prescription Pricing | Application of Alberta's prescription pricing model, Managing drug related problems, transfer of a prescription, Patient care process (accept / assess / document), prescription preparation and checking | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-21 | Seminar/case session | Sem 11 - Prescription Pricing / Documentation | Debrief lab 10, prescription pricing | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-28 | Laboratory | Lab 12 - Patient Care Process - Patient Cues - Pricing | Apply prescription pricing, managing drug related problems, Application of patient care process, Transfer of a prescription | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-11-28 | Seminar/case session | Sem 12 - Prescription Pricing and Medication Adherence | Debrief lab 11, patient centred communication, scope of practice (pharmacists and pharmacy technicians), NOD / SBAR | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-12-05 | Laboratory | Lab 13 - Emotional Patients | Patient care process with an emotional (angry) patient, Complete a simulated “day in the life of a community pharmacist” | D. Barnes |
| PHARM 220 | Y1 | Fall | 2024-12-05 | Final exam | Sem 13 - Final Exam Preparation | Final exam orientation | D. Barnes |
| PHARM 223 | Y1 | Winter | 2025-01-09 | Laboratory | Lab 1 | Insurance navigation, Technical checking | D. Moutlon/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-09 | Seminar/case session | Seminar 1 | Course introduction/expectations, Assessing drug theapy (IESA), Identifying, classifing and stating DRPs | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-16 | Laboratory | Lab 2 | Patient education (eye and ear preparations), DRP identification, classification and statements, LF-Led Interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-16 | Seminar/case session | Seminar 2 | Communicating problems to patients, Patient education, Clinical assessment | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-23 | Laboratory | Lab 3 | Documentation, Patient education (rectal preparations), Patient care process | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-23 | Seminar/case session | Seminar 3 | Minor ailment assessment, Documentation (DAp), Patient education | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-30 | Laboratory | Lab 4 | Documentation, Patient education (lice and warts preparations), DRP identification, classification and statements, LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-30 | Seminar/case session | Seminar 4 | Documentation (daP), Minor Ailments Interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-06 | Laboratory | Lab 5 | Patient education (epi-pen and related devices), Apply principles of medicinal chemistry to allergy assessment , LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-06 | Seminar/case session | Seminar 5 | Clinical Checking | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-13 | Laboratory | Lab 6 | Receiving a compound prescription, Patient education (dandruff, acne), Clinical checking, LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-13 | Seminar/case session | Seminar 6 | Documentation, Complete minor ailments assessment (assessment, recommendation and patient education) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-27 | Laboratory | Lab 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-27 | Seminar/case session | Seminar 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-06 | Laboratory | Lab 8 | Patient care process (minor ailment; database, assessment, plan) [Focus: Dermatology], Patient education (vaginal and nasal preparations), Peer-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-06 | Seminar/case session | Seminar 8 | Midterm debrief | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-13 | Laboratory | Lab 9 | Patient care process (minor ailment; database, assessment, plan) [Focus: Cough & Cold/Seasonal Allergies], Counseling on compounded product from pharmaceutics lab, Patient education (inhalers, peak flow meter, spacers), Peer teaching plan, EBM Application | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-13 | Seminar/case session | Seminar 9 | Minor Ailments Assessment, Application of EBM | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-20 | Laboratory | Lab 10 | Interprofessional collaboration and education, Physical assessment (pulmonary) , Learning plan activity | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-20 | Seminar/case session | Seminar 10 | Learning plan education, Physiotherapy peer activities | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-27 | Laboratory | Lab 11 | Scope of practice (adapt, extend, emergency prescribe, refer), LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-27 | Seminar/case session | Seminar 11 | Scope of practice (extend, adapt, emergency prescribe) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-04-03 | Laboratory | Lab 12 | Patient education (NRT), 1st/3rd year interactions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-04-03 | Seminar/case session | Seminar 12 | Final exam preparation | D. Moulton/E. Leoni |
| PHARM 320 | Y2 | Fall | 2024-09-03 | Laboratory | Lab 1 | Clinical Checking, DRP Statements | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-03 | Seminar/case session | Seminar 1 | Course Introduction, Clinical Checking, DRP Statements | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-10 | Laboratory | Lab 2 | Team Charter, Outpatient Complex Case | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-10 | Seminar/case session | Seminar 2 | Prioritizing DRPs | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-17 | Laboratory | Lab 3 | Goals and Alternatives, Monitoring and Follow-Up, aEHR, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-17 | Seminar/case session | Seminar 3 | Documenting Care Plans, aEHR | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-24 | Laboratory | Lab 4 | Inpatient Pharmacy Practice, BPMH Interaction, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-09-24 | Seminar/case session | Seminar 4 | BPMH, Medication Reconciliation | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-01 | Laboratory | Lab 5 | Ordering Labwork, Drug Information, BPMH Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-01 | Seminar/case session | Seminar 5 | Drug Information | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-08 | Laboratory | Lab 6 | Inpatient Complex Case, Inpatient Discharge, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-08 | Seminar/case session | Seminar 6 | Inpatient Discharge, SBAR, Midterm Preparation | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-22 | Laboratory | Lab 7 | Midterm (Interactive) | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-22 | Seminar/case session | Seminar 7 | Midterm (Non-Interactive) | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-29 | Laboratory | Lab 8 | Inpatient Discharge Interaction, Parenteral Products | Moulton |
| PHARM 320 | Y2 | Fall | 2024-10-29 | Seminar/case session | Seminar 8 | Parenteral Manual | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-05 | Laboratory | Lab 9 | Continence Products, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-05 | Seminar/case session | Seminar 9 | Condition-Specific Assessments | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-12 | Laboratory | Lab 10 | Medical Devices in Diabetes Care | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-12 | Seminar/case session | Seminar 10 | Medical Devices in Diabetes Care | Dylan Moulton (he/him) |
| PHARM 320 | Y2 | Fall | 2024-11-19 | Laboratory | Lab 11 | Drug Interactions, Diabetes Device Counselling, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-19 | Seminar/case session | Seminar 11 | Drug Interactions | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-26 | Laboratory | Lab 12 | Clinical Assessment, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-11-26 | Seminar/case session | Seminar 12 | Physical Assessment, Outpatient Interaction | Moulton |
| PHARM 320 | Y2 | Fall | 2024-12-03 | Laboratory | Lab 13 | Open Lab | Moulton |
| PHARM 320 | Y2 | Fall | 2024-12-03 | Seminar/case session | Seminar 13 | SPoT Survey, Final Exam Preparation | Moulton |
| PHARM 323 | Y2 | Winter | 2025-01-07 | Laboratory | Lab 1 | Introduction, Using interpreters in patient care, Medication-taking tools & technology for people with disabilities | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-07 | Seminar/case session | Seminar 1 | Introduction, Using interpreters in patient care, Medication-taking tools & technology for people with disabilities | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-14 | Laboratory | Lab 2 | Documentation, BP log assessment, GI Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-14 | Seminar/case session | Seminar 2 | Documentation, BP log assessment, GI Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-21 | Laboratory | Lab 3 | Ethics, Point-of-care testing | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-21 | Seminar/case session | Seminar 3 | Ethics, Point-of-care testing | A. Sandhum, L.Tate |
| PHARM 323 | Y2 | Winter | 2025-01-28 | Laboratory | Lab 4 | Scope of Practice, ID Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-01-28 | Seminar/case session | Seminar 4 | Scope of Practice, ID Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-04 | Laboratory | Lab 5 | Integrated Case 1, Heart failure cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-04 | Seminar/case session | Seminar 5 | Integrated Case 1, Heart failure cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-11 | Laboratory | Lab 6 | Monitoring and Follow-up, Cardiology Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-11 | Seminar/case session | Seminar 6 | Monitoring and Follow-up, Heart failure, Nitroglycerin Counselling | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-25 | Laboratory | Lab 7 | MIDTERM | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-02-25 | Seminar/case session | Seminar 7 | MIDTERM | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-04 | Laboratory | Lab 8 | Shared-decision making, Dysphagia and medication administration | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-04 | Seminar/case session | Seminar 8 | Shared-decision making, Dysphagia and medication administration | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-11 | Laboratory | Lab 9 | A day-in-the-life of a hospital pharmacist | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-11 | Seminar/case session | Seminar 9 | Seminar 9 | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-18 | Laboratory | Lab 10 | Integrated Case 2, Vitamin Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-18 | Seminar/case session | Seminar 10 | Integrated Case, Vitamin Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-25 | Laboratory | Lab 11 | Hospital Discharge, Ophthalmology Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-03-25 | Seminar/case session | Seminar 11 | Hospital Discharge, Ophthalmology Cases | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-04-01 | Laboratory | Lab 12 | Death and Dying, Therapeutic Drug Monitoring,Discharge Counselling | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-04-01 | Seminar/case session | Seminar 12 | Death and Dying, Discharge Counselling | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-04-08 | Laboratory | Lab 13 | Dermatology cases, Root cause analysis | A. Sandhu, L. Tate |
| PHARM 323 | Y2 | Winter | 2025-04-08 | Seminar/case session | Seminar 13 | Dermatology cases, Root cause analysis | A. Sandhu, L. Tate |
| PHARM 420 | Y3 | Fall | 2023-09-06 | Laboratory | Lab 1 - Pharmacist scope of practice, applying the patient care process | Pharmacists scope of practice: Verbal Prescriptions Patient Interaction: Applying the patient care process Decision making Implementing a monitoring and follow up plan | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-06 | Seminar/case session | Seminar 1 - Introduction & Foundations | Applying the patient care process, Pharmacists scope of practice, Decision making, Implementing a monitoring and follow up plan | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-13 | Laboratory | Lab 2 - HCM Part 1 | Providing person-centred care using Health Change Methodology: (Virtual online over 2 weeks) Chronic disease management Assessing readiness, importance, confidence and knowledge Understanding barriers to action and facilitators for change | R. Breault |
| PHARM 420 | Y3 | Fall | 2023-09-20 | Laboratory | Lab 3 - Care plan #1 | Providing person-centred care using Health Change Methodology: (Virtual online over 2 weeks) Chronic disease management Assessing readiness, importance, confidence and knowledge Understanding barriers to action and facilitators for change | R. Breault, L. Torok-Both, M. MacDonald |
| PHARM 420 | Y3 | Fall | 2023-09-20 | Seminar/case session | Seminar 3 - Care Plan #1 | Seminar 3 - Care Plan #1 | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-27 | Laboratory | Lab 4 - HCM Part 2 | Patient Interactions: applying person-centered care skills (HCM) - Patient assessment (focus on Diabetes and Pain) Utilizing drug information skills Drug use process and applying standards of practice Assessing patients for deprescribing | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-09-27 | Seminar/case session | Seminar 4 - HCM Part 2 | Chronic disease management, Person-centred care, Applying HealthChange Methodology, Assessing readiness, importance, confidence and knowledge, Understanding barriers to action and facilitators for change | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-04 | Laboratory | Lab 5 - Opioid Prescription Assessment | Lab 5 - Opioid Prescription Assessment | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-04 | Seminar/case session | Seminar 5 - Opioid Prescription Assessment | Drug Use Process and applying standards of practice to opioid prescriptions. Conducting an assessment of opioid prescriptions. | R. Breault, L-Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-11 | Laboratory | Lab 6 - Focus: Women's Health | Patient care: Women’s Health Graded patient interaction 2.5 % Drug use process and applying pharmacist standards of practice Applying critical appraisal skills to clinical decision making Minor ailments | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-11 | Seminar/case session | Seminar 6 - Focus: Women's Health | Women's health, Evidence Based Medicine, Drug use process and applying pharmacist standards of practice Applying critical appraisal skills to clinical decision making Minor ailments | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-10-25 | Laboratory | Lab 7 - Empathy, Patient Counselling (Oncology Focus) | Lab 7 - Empathy, Patient Counselling (Oncology Focus) | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-10-25 | Seminar/case session | Seminar 7 - Empathy/communication | Empathetic communication | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-01 | Laboratory | Lab 8 - Empathy, Palliative Care, Deprescribing | Communicating with patients who are emotionally upset (patient diagnosed with cancer) Applying appropriate standards for the handling of oral cytotoxic drugs | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-01 | Seminar/case session | Seminar 8 - Empathetic Communication | Patient communication in complex scenarios (patients who are dying), Communicating with palliative care patients. Emapathy, Communicating with patients who are emotionally upset (patient diagnosed with cancer) Applying appropriate standards for the handling of oral cytotoxic drugs | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-08 | Laboratory | Lab 9 - Social Determinants of Health, Drug Information, SBAR Practice | Social Determinants of Health, Drug Information and SBAR Practice | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-08 | Seminar/case session | Seminar 9 - Social Determinants of Health | Social Determinants of Health | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-15 | Laboratory | Lab 10 - Neurology Focus, Care Plan #2, Minor Ailments | Scope of practice, ethics, remuneration. Clinical assessment of drug-drug interactions Patient assessment and clinical decision making Patient interaction Neurology focus: Graded 2.5% | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-15 | Seminar/case session | Seminar 10 - Neurology Focus, Care plan #2 | Scope of practice, ethics, remuneration. Clinical assessment of drug-drug interactions Patient assessment and clinical decision making Patient interaction Neurology | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-22 | Seminar/case session | Seminar 11 - Mental Health Focus, Patient Counseling, Documentation | Patient communication in complex scenarios (mental health) Patient assessment (mental health) Applying principles of pharmacology to psychotropic drugs | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-23 | Laboratory | Lab 11 - Mental Health Focus, Patient Counselling, Documentation | Patient communication in complex scenarios (mental health) Patient assessment (mental health) Applying principles of pharmacology to psychotropic drugs | R. Breault, |
| PHARM 420 | Y3 | Fall | 2023-11-29 | Laboratory | Lab 12 - Substance Use Disorders, Vulnerable Populations | Providing care for vulnerable patients Patient communication in complex scenarios (substance use disorders) Naloxone training/Harm Reduction | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-11-29 | Seminar/case session | Seminar 12 - Substance Use Disorder, Vulnerable populations | Providing care for vulnerable patients, Patient communication in complex scenarios (substance use disorders), Naloxone training/Harm Reduction | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-12-06 | Laboratory | Lab 13 - Documentation. Course Wrap up | Shared Care plans Course Evaluation Final Exam information | R. Breault, L. Torok-Both |
| PHARM 420 | Y3 | Fall | 2023-12-06 | Seminar/case session | Seminar 13 - Written Assessment | Seminar 13 - Written Assessment | R. Breault, L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-10 | Laboratory | Lab 1 - Introduction | course Introduction, patient counselling, scope of Practice | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-10 | Seminar/case session | Sem 1 - Introduction | Course Introduction, Patient counselling, Scope of Practice | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-17 | Laboratory | Lab 2 - Patient Consent | Patient consent | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-17 | Seminar/case session | Sem 2 - Patient Consent | Patient consent, Ambulatory Care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-24 | Laboratory | Lab 3 - Injection training | Injection training | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-24 | Seminar/case session | Sem 3 - Injection training | Injection training | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-26 | Laboratory | Injection Authorization | Injections | Lindsay Torok-Both (Secondary Coordinator), Gillian Johnson (Lab Coordinator), Damion Barnes (Primary Coordinator) |
| PHARM 423 | Y3 | Winter | 2024-01-31 | Laboratory | Lab 4 - Pharmacists in Emergencies | Disaster planning, Providng care in emergencies, Emergency prescribing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-01-31 | Seminar/case session | Sem 4 - Pharmacists in Emergencies | Disaster planning, Providng care in emergencies, Emergency prescribing | K. Watson |
| PHARM 423 | Y3 | Winter | 2024-02-07 | Laboratory | Lab 5 - Discrimination, racism and bias in healthcare | Emergency care, Discrimination and racism | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-07 | Seminar/case session | Sem 5 - Discrimination, racism and bias in healthcare | Emergency care, Discrimination and racism | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-14 | Laboratory | Lab 6 - Inclusivity in Care of SOGIE clients | Reproductive health, PrEP, Care of SOGIE clients | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-14 | Seminar/case session | Sem 6 - Inclusivity in the care of SOGIE clients | Reproductive health, PrEP, Care of SOGIE clients | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-28 | Laboratory | Lab 7 - Deprescribing | Deprescribing, Medication management, Geriatric care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-02-28 | Seminar/case session | Sem 7 - Deprescribing | Deprescribing, Medication management, Geriatric care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-06 | Laboratory | Lab 8 - Death and Dying | Death and Dying, Ambiguous situations | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-06 | Seminar/case session | Sem 8 - Death and Dying | Death and Dying | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-13 | Laboratory | Lab 9 - Ambiguity in CDM & Ambulatory Assistive Devices | Ambulatory Assistive Devices, Elder Care | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-13 | Seminar/case session | Sem 9 -Ambiguity in CDM | Ambiguity in decision making | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-20 | Laboratory | Lab 10 - Sexual Health | Sexual histories, STBBIs, Point of care testing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-20 | Seminar/case session | Sem 10 - Sexual Health | Sexual histories, STBBIs, Point of care testing | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-27 | Laboratory | Lab 11 - Providing feedback | Feedback to other students | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-03-27 | Seminar/case session | Sem 11 - Providing feedback | Feedback to other students, Patient counselling | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-03 | Laboratory | Lab 12 - Travel Health | Travel health, Difficult discussions with providers | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-03 | Seminar/case session | Sem 12 - Travel Health | Travel health, Difficult discussions with prescribers | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-10 | Laboratory | Lab 13 - Review Lab | Semester Review, Transplant, Create your own case | D. Barnes & L. Torok-Both |
| PHARM 423 | Y3 | Winter | 2024-04-10 | Seminar/case session | Sem 13 - Written Assessment | Written assessment | D. Barnes & L. Torok-Both |
Assessment Information
| PHARM 215 | Y1 | Assignment 1 | Assignment/written work | 20% | — |
| PHARM 215 | Y1 | Assignment 2 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Assignment 3 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Assignment 4 | Assignment/written work | 10% | — |
| PHARM 215 | Y1 | Comprehensive Module Assessment | Other exam/test | 50% | — |
| PHARM 220 | Y1 | Final Exam (40%) | Final exam | 40% | — |
| PHARM 220 | Y1 | Midterm Exam (25%) | Midterm exam | 25% | — |
| PHARM 220 | Y1 | Professionalism (5%) | Participation/professionalism | 5% | — |
| PHARM 220 | Y1 | Lab Assignments and Quizzes (30%) | Quiz | 30% | — |
| PHARM 223 | Y1 | Critical Reflection | Assignment/written work | 5% | — |
| PHARM 223 | Y1 | Lab Assignments | Assignment/written work | 25% | — |
| PHARM 223 | Y1 | Final Exam | Final exam | 35% | — |
| PHARM 223 | Y1 | Midterm Exam | Midterm exam | 25% | — |
| PHARM 223 | Y1 | Medical Terminology | Other/unspecified | 5% | — |
| PHARM 223 | Y1 | Professionalism Mark | Participation/professionalism | 5% | — |
| PHARM 223 | Y1 | Medical Terminology | Quiz | 5% | — |
| PHARM 320 | Y2 | Care Plan Assignment | Assignment/written work | 10% | — |
| PHARM 320 | Y2 | Critical Reflection | Assignment/written work | 5% | — |
| PHARM 320 | Y2 | Integrated Care Plan | Assignment/written work | 10% | — |
| PHARM 320 | Y2 | Lab Activities | Assignment/written work | 20% | — |
| PHARM 320 | Y2 | Lab Assignments | Assignment/written work | 30% | — |
| PHARM 320 | Y2 | Final | Final exam | 30% | — |
| PHARM 320 | Y2 | Final | Final exam | 30% | — |
| PHARM 320 | Y2 | Midterm | Midterm exam | 30% | — |
| PHARM 320 | Y2 | Midterm | Midterm exam | 30% | — |
| PHARM 320 | Y2 | — | Other/unspecified | 0% | — |
| PHARM 320 | Y2 | Professionalism Mark | Participation/professionalism | 5% | — |
| PHARM 323 | Y2 | Integrated Cases | Assignment/written work | 10% | — |
| PHARM 323 | Y2 | Lab Assignments | Assignment/written work | 25% | — |
| PHARM 323 | Y2 | Final Exam | Final exam | 35% | — |
| PHARM 323 | Y2 | Midterm | Midterm exam | 25% | — |
| PHARM 323 | Y2 | Professionalism | Participation/professionalism | 5% | — |
| PHARM 420 | Y3 | Care Plan Assignments | Assignment/written work | 16% | — |
| PHARM 420 | Y3 | Final | Final exam | 40% | — |
| PHARM 420 | Y3 | Written Assessment | Other exam/test | 20% | — |
| PHARM 420 | Y3 | Lab Assignments and Quizzes | Quiz | 24% | — |
| PHARM 423 | Y3 | Additional Prescribing Authority Preparedness Reflection (10%) | Assignment/written work | 10% | — |
| PHARM 423 | Y3 | Lab Assignments (30%) | Assignment/written work | 30% | — |
| PHARM 423 | Y3 | OSCE (40%) | OSCE | 40% | — |
| PHARM 423 | Y3 | Written Assessment 20% | Other exam/test | 20% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 215 — PHARM 215 - Pharmaceutical Calculations | Y1 | Fall | 11 | 4 | 0 | Assignment/written work (4); Final exam (1); Quiz (2) | This course focuses on the fundamental principles of calculaJons performed by pharmacists in various pracJcal seLngs. |
| PHARM 220 — Patient Care Skills 1 | Y1 | Fall | 0 | 11 | 11 | Final exam (1); Participation/professionalism (1); Quiz (1) | 3 (fi 6) (first term, 0-1s-3) Introduces students to the patient care process and how to apply it, with an emphasis on creating the patient database in a community pharmacy setting. Students will develop fundamental skills required of a pharmacist, including communication skills, interprofessional collaboration, medical terminology, pharmaceutical calculations, and drug information. (Restricted to Pharmacy students.) |
| PHARM 223 — Skills 2 | Y1 | Winter | 0 | 9 | 11 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | 3 (fi 6) (second term, 0-1s-3) Students will apply knowledge and further develop skills using the patient care process, focusing on creating the patient database and introducing patient assessment and pharmacotherapy work-up in a community pharmacy setting in order to prepare the student for practice experiences. (Restricted to Pharmacy students.) This course will build on skills learned in Patient Care Skills 1 and will integrate therapeutic and pharmaceutical topics covered in Year 1 second semester. Students will apply knowledge and develop skills needed by a pharmacist to provide patient care, using a systematic process to define and achieve the goals of optimizing safe, effective pharmacotherapy. Students will continue to develop abilities in professionalism, communication, critical thinking, problem-solving, teamwork, and self-directed learning. Students will identify, resolve and prevent drug-related problems, and provide a variety of patient education. Students will further develop drug information, evidence-based medicine and pharmaceutical calculation skills. Sessions are designed to facilitate collaborative learning that will be transferable to diverse practice settings, with a focus on the community setting to prepare the student for their experiential learning at the end of Year 1. |
| PHARM 320 — Patient Care Skills 3 | Y2 | Fall | 19 | 1 | 5 | Assignment/written work (2); Final exam (1); Participation/professionalism (1) | Students will continue to apply knowledge and develop skills required by a pharmacist to provide patient care, using a systematic process to define and achieve the goals of optimizing safe, effective pharmacotherapy. Students will also continue to develop abilities in professionalism, communication, critical thinking, problem-solving, teamwork and self-directed learning. Sessions are designed to facilitate collaborative learning that will be transferable to diverse practice settings, with an introduction to inpatient settings in order to prepare the student for practice experiences. (Restricted to Pharmacy students). |
| PHARM 323 — PHARM 323 - Patient Care Skills 4 | Y2 | Winter | 0 | 12 | 12 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1) | Students will apply knowledge and develop skills required by a pharmacist to provide patient care, using a systematic process to define and achieve the goals of optimizing safe and effective pharmacotherapy. Students will continue to develop abilities in professionalism, communication, critical thinking, problem-solving, teamwork and self-directed learning. Students will identify, resolve and prevent drug related problems increasing in complexity, and will further develop their patient education, and drug information skills. Sessions are designed to facilitate collaborative learning that will be transferable to diverse practice settings, with more emphasis on the hospital setting. (Restricted to Pharmacy students.) |
| PHARM 420 — Patient Care Skills 5 | Y3 | Fall | 0 | 12 | 2 | Assignment/written work (2); OSCE (1); Participation/professionalism (1) | ★ 3 (fi 6) (first term, 0-1s-3) Focus will be on advanced practice concepts including prescribing and the application of the patient care process to more complex patient scenarios and chronic diseases. Further development of skills in patient assessment, communication, medication therapy management, and evidence-based practice will be undertaken within the context of various practice environments. Peer mentoring and lifelong learning will also be examined. (Restricted to Pharmacy students.) |
| PHARM 423 — Patient Care Skills 6 | Y3 | Winter | 2 | 12 | 12 | Assignment/written work (2); Final exam (1); OSCE (1); Participation/professionalism (1) | The focus is on advanced practice concepts, including patient assessment, communication, medication therapy management, evidence-based practice, and critical thinking and decision-making skills to address complex drug therapy problems. (Restricted to Pharmacy students.) |
Session Information
| PHARM 215 | Y1 | Fall | 2025-09-04 | Quiz | Part 1: Introduction to Math (Topics, instructors, quizzes, assignments, grading, references, academic integrity); Part 2: Units, Unit Conversion (weight, length, temperature) | Part 1: Introduction to Math (Topics, instructors, quizzes, assignments, grading, references, academic integrity); Part 2: Units, Unit Conversion (weight, length, temperature) | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-09-11 | Lecture | Pharmaceutical Measurements, Balance, Accuracy and Precision; Error/Sensitivity, Significant Figures, Rounding | Pharmaceutical Measurements, Balance, Accuracy and Precision; Error/Sensitivity, Significant Figures, Rounding | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-09-18 | Lecture | Dosage Calculations (by age, weight, BSA, special population) | Dosage Calculations (by age, weight, BSA, special population) | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-09-18 | Seminar/case session | Review Lecture 1 & 2 | Review Lecture 1 & 2 | — |
| PHARM 215 | Y1 | Fall | 2025-09-25 | Lecture | Amount of Active Ingredients, Density, Specific Gravity | Amount of Active Ingredients, Density, Specific Gravity | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-10-02 | Lecture | Concentrations, Dilutions, Aliquot Method, Percentage- 1 | Concentrations, Dilutions, Aliquot Method, Percentage- 1 | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-10-09 | Lecture | Concentrations, Dilutions, Aliquot Method, Percentage -2 | Concentrations, Dilutions, Aliquot Method, Percentage -2 | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-10-16 | Seminar/case session | Review Assignments 1; Quiz-1 | Review Assignments 1; Quiz-1 | — |
| PHARM 215 | Y1 | Fall | 2025-10-16 | Lecture | pH, Buffer Solution, Buffer Capacity | pH, Buffer Solution, Buffer Capacity | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-10-23 | Lecture | Alligation Method, Reducing/Enlarging Formula | Alligation Method, Reducing/Enlarging Formula | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-10-30 | Lecture | Milliequivalents/Millimoles, Electrolyte Solution | Milliequivalents/Millimoles, Electrolyte Solution | G. Johnson |
| PHARM 215 | Y1 | Fall | 2025-11-06 | Lecture | Powder Volume Displacement in Liquids; Intravenous Flow/ Infusion Rates | Powder Volume Displacement in Liquids; Intravenous Flow/ Infusion Rates | G. Johnson |
| PHARM 215 | Y1 | Fall | 2025-11-06 | Seminar/case session | Review Assignments 2, 3 | Review Assignments 2, 3 | — |
| PHARM 215 | Y1 | Fall | 2025-11-20 | Lecture | Osmolarity and Tonicity of Solutions | Osmolarity and Tonicity of Solutions | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-11-27 | Lecture | Application of Pharmaceutical Calculations in Analytical Techniques | Application of Pharmaceutical Calculations in Analytical Techniques | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-12-04 | Other exam/test | Calculation Examples; Course Review | Calculation Examples; Course Review | F. Sanaee |
| PHARM 215 | Y1 | Fall | 2025-12-04 | Seminar/case session | Review Assignments 4; Quiz-2 | Review Assignments 4; Quiz-2 | — |
| PHARM 215 | Y1 | Fall | 2025-12-08 | Other exam/test | Exam | Exam (final comprehensive assessment) | F. Sanaee; G. Johnson |
| PHARM 220 | Y1 | Fall | 2025-09-04 | Workshop | Communication Workshop | Communicating with Confidence | — |
| PHARM 220 | Y1 | Fall | 2025-09-04 | Seminar/case session | Seminar 1 | Course introduction, professionalism, patient care process | — |
| PHARM 220 | Y1 | Fall | 2025-09-11 | Laboratory | Lab 1 | Lab orientation, team integration, community pharmacy orientation, prescription basics | — |
| PHARM 220 | Y1 | Fall | 2025-09-11 | Seminar/case session | Seminar 2 | Debrief lab 1, patient care process, peer feedback | — |
| PHARM 220 | Y1 | Fall | 2025-09-18 | Laboratory | Lab 2 | Patient care process (gathering information), peer feedback, patient experience, prescription filling | — |
| PHARM 220 | Y1 | Fall | 2025-09-18 | Seminar/case session | Seminar 3 | Debrief lab 2, introduction to information management system | — |
| PHARM 220 | Y1 | Fall | 2025-09-25 | Laboratory | Lab 3 | Patient interview, training on information management system, patient care process (initial patient assessment), prescription filling | — |
| PHARM 220 | Y1 | Fall | 2025-09-25 | Seminar/case session | Seminar 4 | Debrief lab 3, reflective practice | — |
| PHARM 220 | Y1 | Fall | 2025-10-02 | Laboratory | Lab 4 | Patient care process (gathering and documenting information), prescription processing, reflection | — |
| PHARM 220 | Y1 | Fall | 2025-10-02 | Seminar/case session | Seminar 5 | Debrief lab 4, receipt of a verbal prescription, NOD/SBAR | — |
| PHARM 220 | Y1 | Fall | 2025-10-09 | Laboratory | Lab 5 | Patient care process (gathering and documenting information, assessing indication and safety), technical prescription checking, verbal orders, reflection | — |
| PHARM 220 | Y1 | Fall | 2025-10-09 | Seminar/case session | Seminar 6 | Debrief lab 5, patient care process (refill medication) | — |
| PHARM 220 | Y1 | Fall | 2025-10-16 | Laboratory | Lab 6 | Patient care process (refill medication), legal assessment of a prescription, verbal orders | — |
| PHARM 220 | Y1 | Fall | 2025-10-23 | Other/unspecified | Asynchronous Activities | Prescription processing, technical prescription checking | — |
| PHARM 220 | Y1 | Fall | 2025-10-23 | Seminar/case session | Seminar 7 | Debrief lab 6 | — |
| PHARM 220 | Y1 | Fall | 2025-10-30 | Laboratory | Lab 8 | Drug information inquiry (receipt of request), written responses to answer drug information inquiries, Netcare introduction | — |
| PHARM 220 | Y1 | Fall | 2025-10-30 | Seminar/case session | Seminar 8 | Drug information resources when assessing a prescription, patient care process (refill medication) | — |
| PHARM 220 | Y1 | Fall | 2025-10-30 | Seminar/case session | Seminar 9 | Debrief lab 8, best possible medication history, drug therapy problems | — |
| PHARM 220 | Y1 | Fall | 2025-11-06 | Laboratory | Lab 9 | Best possible medication history, refills/ongoing therapy, identifying drug therapy problems | — |
| PHARM 220 | Y1 | Fall | 2025-11-10 | No class | FALL BREAK - NO CLASSES | Fall break period (no classes) | — |
| PHARM 220 | Y1 | Fall | 2025-11-20 | Laboratory | Lab 10 | Documentation notes, assessing adherence, identifying drug therapy problems, refills/ongoing therapy | — |
| PHARM 220 | Y1 | Fall | 2025-11-20 | Seminar/case session | Seminar 11 | Debrief lab 10, prescription transfer | — |
| PHARM 220 | Y1 | Fall | 2025-11-27 | Laboratory | Lab 11 | Apply prescription pricing, identifying and prioritizing drug therapy problems, prescription transfers | — |
| PHARM 220 | Y1 | Fall | 2025-11-27 | Final exam | Seminar 12 | Debrief lab 11, conflict management, final exam overview | — |
| PHARM 220 | Y1 | Fall | 2025-12-04 | Laboratory | Lab 12 | Patient care process with an emotional (angry) patient, “day in the life of a community pharmacist” simulation | — |
| PHARM 220 | Y1 | Fall | 2025-12-11 | Final exam | Final Exam | Final OSCE exam | — |
| PHARM 220 | Y1 | Fall | — | Seminar/case session | Seminar 10 | Debrief lab 9, documentation notes, assessing adherence | — |
| PHARM 223 | Y1 | Winter | 2025-01-09 | Laboratory | Lab 1 | Insurance navigation, Technical checking | D. Moutlon/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-09 | Seminar/case session | Seminar 1 | Course introduction/expectations, Assessing drug theapy (IESA), Identifying, classifing and stating DRPs | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-16 | Laboratory | Lab 2 | Patient education (eye and ear preparations), DRP identification, classification and statements, LF-Led Interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-16 | Seminar/case session | Seminar 2 | Communicating problems to patients, Patient education, Clinical assessment | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-23 | Laboratory | Lab 3 | Documentation, Patient education (rectal preparations), Patient care process | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-23 | Seminar/case session | Seminar 3 | Minor ailment assessment, Documentation (DAp), Patient education | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-30 | Laboratory | Lab 4 | Documentation, Patient education (lice and warts preparations), DRP identification, classification and statements, LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-01-30 | Seminar/case session | Seminar 4 | Documentation (daP), Minor Ailments Interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-06 | Laboratory | Lab 5 | Patient education (epi-pen and related devices), Apply principles of medicinal chemistry to allergy assessment, LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-06 | Seminar/case session | Seminar 5 | Clinical Checking | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-13 | Laboratory | Lab 6 | Receiving a compound prescription, Patient education (dandruff, acne), Clinical checking, LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-13 | Seminar/case session | Seminar 6 | Documentation, Complete minor ailments assessment (assessment, recommendation and patient education) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-27 | Midterm exam | Lab 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-02-27 | Midterm exam | Seminar 7 | Midterm | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-06 | Laboratory | Lab 8 | Patient care process (minor ailment; database, assessment, plan) [Focus: Dermatology], Patient education (vaginal and nasal preparations), Peer-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-06 | Midterm exam | Seminar 8 | Midterm debrief | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-13 | Laboratory | Lab 9 | Patient care process (minor ailment; database, assessment, plan) [Focus: Cough & Cold/Seasonal Allergies], Counseling on compounded product from pharmaceutics lab, Patient education (inhalers, peak flow meter, spacers), Peer teaching plan, EBM Application | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-13 | Seminar/case session | Seminar 9 | Minor Ailments Assessment, Application of EBM | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-20 | Laboratory | Lab 10 | Interprofessional collaboration and education, Physical assessment (pulmonary), Learning plan activity | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-20 | Seminar/case session | Seminar 10 | Learning plan education, Physiotherapy peer activities | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-27 | Laboratory | Lab 11 | Scope of practice (adapt, extend, emergency prescribe, refer), LF-led interaction | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-03-27 | Seminar/case session | Seminar 11 | Scope of practice (extend, adapt, emergency prescribe) | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-04-03 | Laboratory | Lab 12 | Patient education (NRT), 1st/3rd year interactions | D. Moulton/E. Leoni |
| PHARM 223 | Y1 | Winter | 2025-04-03 | Final exam | Seminar 12 | Final exam preparation | D. Moulton/E. Leoni |
| PHARM 320 | Y2 | Fall | 2025-09-02 | Lecture | Clinical Checking, DRP Statements | Clinical Checking, DRP Statements | Salokangas |
| PHARM 320 | Y2 | Fall | 2025-09-02 | Lecture | Course Introduction, Clinical Checking, DRP Statements | Course Introduction, Clinical Checking, DRP Statements | Salokangas |
| PHARM 320 | Y2 | Fall | 2025-09-09 | Lecture | Prioritizing DRPs | Prioritizing DRPs | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-09-09 | Lecture | Team Charter, Outpatient Complex Case | Team Charter, Outpatient Complex Case | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-09-16 | Lecture | Extension of the patient care process/documenting care plans (Assessment/Plan), aEHR | Extension of the patient care process/documenting care plans (Assessment/Plan), aEHR | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-09-16 | Lecture | Outpatient Complex Case pt. II, Outpatient Interaction | Outpatient Complex Case pt. II, Outpatient Interaction | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-09-23 | Lecture | BPMH, Medication Reconciliation | BPMH, Medication Reconciliation | Tate |
| PHARM 320 | Y2 | Fall | 2025-09-23 | Lecture | Inpatient Pharmacy Practice, Therapeutic Interchange, BPMH Interaction | Inpatient Pharmacy Practice, Therapeutic Interchange, BPMH Interaction | Tate |
| PHARM 320 | Y2 | Fall | 2025-09-30 | Laboratory | No class or lab | No class or lab | — |
| PHARM 320 | Y2 | Fall | 2025-10-07 | Lecture | Drug Information | Drug Information | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-07 | Laboratory | Ordering Labwork, Drug Information, BPMH Interaction | Ordering Labwork, Drug Information, BPMH Interaction | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-14 | Lecture | Inpatient Complex Case, Inpatient Discharge, Outpatient Interaction | Inpatient Complex Case, Inpatient Discharge, Outpatient Interaction | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-14 | Lecture | Inpatient Discharge, SBAR, Care Plan Assignment | Inpatient Discharge, SBAR, Care Plan Assignment | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-21 | Lecture | Inpatient Discharge Interaction, Parenteral Products, Managing Electrolyte Abnormalities | Inpatient Discharge Interaction, Parenteral Products, Managing Electrolyte Abnormalities | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-21 | Lecture | Parenteral Manual, Discharge Prescriptions | Parenteral Manual, Discharge Prescriptions | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-28 | Seminar/case session | No seminar | No seminar | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-10-28 | Laboratory | Open lab | Open lab | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-11-04 | Lecture | Continence Products, Outpatient Interaction | Continence Products, Outpatient Interaction | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-11-04 | Lecture | DRP Reset, Condition-Specific Assessments | DRP Reset, Condition-Specific Assessments | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-11-11 | Laboratory | No class or lab | No class or lab | — |
| PHARM 320 | Y2 | Fall | 2025-11-18 | Lecture | Medical Devices in Diabetes Care | Medical Devices in Diabetes Care | — |
| PHARM 320 | Y2 | Fall | 2025-11-18 | Lecture | Medical Devices in Diabetes Care | Medical Devices in Diabetes Care | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-11-25 | Lecture | Clinical Assessment, Outpatient Interaction, Diabetes Device Counselling | Clinical Assessment, Outpatient Interaction, Diabetes Device Counselling | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-11-25 | Lecture | Physical Assessment, Outpatient Interaction | Physical Assessment, Outpatient Interaction | Salokangas |
| PHARM 320 | Y2 | Fall | 2025-12-02 | Laboratory | Clinical Assessment, Outpatient Interaction, Open lab | Clinical Assessment, Outpatient Interaction, Open lab | Salokangas; Tate |
| PHARM 320 | Y2 | Fall | 2025-12-02 | Final exam | SPoT Survey, Final Exam Preparation | SPoT Survey, Final Exam Preparation | Salokangas; Tate |
| PHARM 323 | Y2 | Winter | 2025-01-07 | Laboratory | Lab 1 | Medication-taking tools & technology for people with disabilities | — |
| PHARM 323 | Y2 | Winter | 2025-01-07 | Seminar/case session | Seminar 1 | Introduction, Using interpreters in patient care, Medication-taking tools & technology for people with disabilities | — |
| PHARM 323 | Y2 | Winter | 2025-01-14 | Laboratory | Lab 2 | Lab 2 | — |
| PHARM 323 | Y2 | Winter | 2025-01-14 | Seminar/case session | Seminar 2 | Documentation, BP log assessment, GI Cases | — |
| PHARM 323 | Y2 | Winter | 2025-01-21 | Laboratory | Lab 3 | Lab 3 | — |
| PHARM 323 | Y2 | Winter | 2025-01-21 | Seminar/case session | Seminar 3 | Ethics, Point-of-care testing | — |
| PHARM 323 | Y2 | Winter | 2025-01-28 | Laboratory | Lab 4 | Lab 4 | — |
| PHARM 323 | Y2 | Winter | 2025-01-28 | Seminar/case session | Seminar 4 | Scope of Practice, ID Cases, How to present a patient | — |
| PHARM 323 | Y2 | Winter | 2025-02-04 | Laboratory | Lab 5 | Lab 5 | — |
| PHARM 323 | Y2 | Winter | 2025-02-04 | Seminar/case session | Seminar 5 | Integrated Case 1, Heart failure cases | — |
| PHARM 323 | Y2 | Winter | 2025-02-11 | Laboratory | Lab 6 | Lab 6 | — |
| PHARM 323 | Y2 | Winter | 2025-02-11 | Seminar/case session | Seminar 6 | Monitoring and Follow-up, Cardiology Cases, | — |
| PHARM 323 | Y2 | Winter | 2025-02-25 | Midterm exam | Lab 7 | MIDTERM Interactive Station | — |
| PHARM 323 | Y2 | Winter | 2025-02-25 | Midterm exam | Seminar 7 | MIDTERM Written station | — |
| PHARM 323 | Y2 | Winter | 2025-03-04 | Laboratory | Lab 8 | administration | — |
| PHARM 323 | Y2 | Winter | 2025-03-04 | Seminar/case session | Seminar 8 | Shared-decision making, Dysphagia and medication | — |
| PHARM 323 | Y2 | Winter | 2025-03-11 | Laboratory | Lab 9 | presentations | — |
| PHARM 323 | Y2 | Winter | 2025-03-11 | Seminar/case session | Seminar 9 | A day-in-the-life of a hospital pharmacist, Case | — |
| PHARM 323 | Y2 | Winter | 2025-03-18 | Laboratory | Lab 10 | Lab 10 | — |
| PHARM 323 | Y2 | Winter | 2025-03-18 | Seminar/case session | Seminar 10 | Integrated Case, Vitamin Cases | — |
| PHARM 323 | Y2 | Winter | 2025-03-25 | Laboratory | Lab 11 | Lab 11 | — |
| PHARM 323 | Y2 | Winter | 2025-03-25 | Seminar/case session | Seminar 11 | Hospital Discharge, Ophthalmology Cases | — |
| PHARM 323 | Y2 | Winter | 2025-04-01 | Laboratory | Lab 12 | Counselling | — |
| PHARM 323 | Y2 | Winter | 2025-04-01 | Seminar/case session | Seminar 12 | Death and Dying, Therapeutic Drug Monitoring, Discharge | — |
| PHARM 323 | Y2 | Winter | 2025-04-08 | Laboratory | Lab 13 | Counselling | — |
| PHARM 323 | Y2 | Winter | 2025-04-08 | Seminar/case session | Seminar 13 | Dermatology cases, Root cause analysis, Discharge | — |
| PHARM 420 | Y3 | Fall | 2025-09-04 | Seminar/case session | Introductory Seminar; Seminar 1 (Introductory Lab) | Course Introduction and Expectations; Primary Care Skills Training - Introductory Module; Introductory Lab | — |
| PHARM 420 | Y3 | Fall | 2025-09-11 | Seminar/case session | Seminar / Lab 1 | Interprofessional communication; Lab 1 | — |
| PHARM 420 | Y3 | Fall | 2025-09-18 | Seminar/case session | Seminar 2; Lab 2; Seminar 3 | Primary Care Skills; Graded Interaction #1; Applying Person-Centred Care Using Health Change Methodology® Part 1 | — |
| PHARM 420 | Y3 | Fall | 2025-09-25 | Seminar/case session | Lab 3; Seminar 4 | Care planning/Chronic Disease Management in Primary Care; Lab 3 | — |
| PHARM 420 | Y3 | Fall | 2025-10-02 | Seminar/case session | Lab 4; Seminar 5 | Care planning - Case 1; Applying Person-Centred Care Using Health Change Methodology® | — |
| PHARM 420 | Y3 | Fall | 2025-10-09 | Seminar/case session | Lab 5; Seminar 6 | Applying Person-Centred Care Using Health Change Methodology® Part 2; Opioid use assessment in primary care | — |
| PHARM 420 | Y3 | Fall | 2025-10-16 | Laboratory | Lab 6 | Drug Information Questions; Lab 6 | — |
| PHARM 420 | Y3 | Fall | 2025-10-23 | Seminar/case session | No Lab or Seminar | No Lab or Seminar | — |
| PHARM 420 | Y3 | Fall | 2025-10-25 | Seminar/case session | Lab 7; Seminar 8 | Intraprofessional Lab with Pharmacy Technician Students; Patient care: Women’s and Men’s Health - Graded Interaction #2 | — |
| PHARM 420 | Y3 | Fall | 2025-10-30 | Laboratory | Lab 8 | Using NIHB process in primary care; Lab 8 | — |
| PHARM 420 | Y3 | Fall | 2025-11-06 | Seminar/case session | Seminar 9; Lab 9 | Responding to a negative interaction with another HCP; Practicing empathetic communication; Patient communication in complex scenarios (Mental health conditions, patients who are end of life); Care plan #2 | — |
| PHARM 420 | Y3 | Fall | 2025-11-13 | Seminar/case session | No seminar or lab | No seminar or lab | — |
| PHARM 420 | Y3 | Fall | 2025-11-20 | Seminar/case session | Seminar 10; Lab 10 | Assessing Social Determinants of Health in the primary care setting; Minor ailments, Drug Information and Patient Counseling; Drug Shortages | — |
| PHARM 420 | Y3 | Fall | 2025-11-27 | Seminar/case session | Seminar 11; Lab 11 | Graded interaction #3; Naloxone training/Harm Reduction; Providing Care Virtually | — |
| PHARM 420 | Y3 | Fall | 2025-12-04 | Final exam | Seminar 12; Lab 12 | Course Wrap up, Final Exam Information; Providing care for vulnerable patients in primary care; Patient communication in complex scenarios (substance use disorders) | — |
| PHARM 420 | Y3 | Fall | 2025-12-17 | Final exam | Final Exam | Final Exam - OSCE - 40% | — |
| PHARM 423 | Y3 | Winter | 2026-01-07 | Laboratory | Consent | Consent | — |
| PHARM 423 | Y3 | Winter | 2026-01-07 | Seminar/case session | Course Introduction, Prescription Assessment, Patient | Course Introduction, Prescription Assessment, Patient | — |
| PHARM 423 | Y3 | Winter | 2026-01-14 | Seminar/case session | Injection Consent, Longitudinal Cases, Vaccine Hesitancy | Injection Consent, Longitudinal Cases, Vaccine Hesitancy | — |
| PHARM 423 | Y3 | Winter | 2026-01-14 | Laboratory | LAB 2 | LAB 2 | — |
| PHARM 423 | Y3 | Winter | 2026-01-21 | Seminar/case session | Injection Training | Injection Training | — |
| PHARM 423 | Y3 | Winter | 2026-01-21 | Laboratory | LAB 3 | LAB 3 | — |
| PHARM 423 | Y3 | Winter | 2026-01-23 | Lecture | Injection Certification | Injection Certification | — |
| PHARM 423 | Y3 | Winter | 2026-01-28 | Laboratory | Interaction | Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-01-28 | Seminar/case session | Providing Care in Emergencies, Toxicology, Patient | Providing Care in Emergencies, Toxicology, Patient | — |
| PHARM 423 | Y3 | Winter | 2026-02-04 | Laboratory | LAB 5 | LAB 5 | — |
| PHARM 423 | Y3 | Winter | 2026-02-04 | Seminar/case session | Longitudinal Cases, Toxicology, Patient Interaction | Longitudinal Cases, Toxicology, Patient Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-02-11 | Laboratory | LAB 6 | LAB 6 | — |
| PHARM 423 | Y3 | Winter | 2026-02-11 | Seminar/case session | Longitudinal Cases, Scope of Practice, Patient Interaction | Longitudinal Cases, Scope of Practice, Patient Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-02-25 | Laboratory | LAB 7 | LAB 7 | — |
| PHARM 423 | Y3 | Winter | 2026-02-25 | Seminar/case session | Longitudinal Cases, Patient Interaction | Longitudinal Cases, Patient Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-03-04 | Laboratory | Interaction | Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-03-04 | Seminar/case session | Medication Management, Patient Counseling, Patient | Medication Management, Patient Counseling, Patient | — |
| PHARM 423 | Y3 | Winter | 2026-03-11 | Seminar/case session | Ambulatory Assistive Devices, Prescription Assessment, | Ambulatory Assistive Devices, Prescription Assessment, | — |
| PHARM 423 | Y3 | Winter | 2026-03-11 | Laboratory | Patient Interaction | Patient Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-03-18 | Other exam/test | Point-of-care Testing | Point-of-care Testing | — |
| PHARM 423 | Y3 | Winter | 2026-03-18 | Seminar/case session | Sexual Health, Pre-exposure Prophylaxis, STBBIs, | Sexual Health, Pre-exposure Prophylaxis, STBBIs, | — |
| PHARM 423 | Y3 | Winter | 2026-03-25 | Laboratory | Prescription Assessment, Patient Interaction | Prescription Assessment, Patient Interaction | — |
| PHARM 423 | Y3 | Winter | 2026-03-25 | Seminar/case session | Transplant, Managing Disagreements with Providers, | Transplant, Managing Disagreements with Providers, | — |
| PHARM 423 | Y3 | Winter | 2026-04-01 | Laboratory | LAB 12 | LAB 12 | — |
| PHARM 423 | Y3 | Winter | 2026-04-01 | Final exam | SPoT, Final Exam Preparation, Medication Management, Providing Feedback | SPoT, Final Exam Preparation, Medication Management, Providing Feedback | — |
| PHARM 423 | Y3 | Winter | 2026-04-02 | Lecture | Providing feedback to the learning of near-peers | Providing feedback to the learning of near-peers | — |
| PHARM 423 | Y3 | Winter | 2026-04-08 | Seminar/case session | Non-interactive Assessment | Non-interactive Assessment | — |
| PHARM 423 | Y3 | Winter | 2026-04-08 | Laboratory | Open Lab | Open Lab | — |
| PHARM 423 | Y3 | Winter | — | No class | Reading Week | Reading Week | — |
Assessment Information
| PHARM 215 | Y1 | Assignment 1 | Assignment/written work | 10% | Four individual assignments (10% each). Various question formats (MCQ, matching, short answer). Must achieve 100% to proceed; two additional attempts allowed; late policy allows up to 24h late with max 80% for inexcusable late. |
| PHARM 215 | Y1 | Assignment 2 | Assignment/written work | 10% | Assignment (10%) with same rules as other assignments: individual, various formats, must achieve 100% to proceed, two additional attempts, late policy described. |
| PHARM 215 | Y1 | Assignment 3 | Assignment/written work | 10% | Assignment (10%) with standard assignment rules (individual, various formats, must reach 100%, two additional attempts, late policy). |
| PHARM 215 | Y1 | Assignment 4 | Assignment/written work | 10% | Assignment (10%) with standard assignment rules (individual, various formats, must reach 100%, two additional attempts, late policy). |
| PHARM 215 | Y1 | Final Assessment | Final exam | 50% | Comprehensive final assessment (50%) consisting of MCQ and short-answer questions; cumulative; minimum 80% on final required for CR; one permitted retake if not passed on first attempt. |
| PHARM 215 | Y1 | Quiz 1 | Quiz | 5% | In-class short quiz (5-7 questions; MCQ and short answer) worth 5%, administered during Seminar 2. |
| PHARM 215 | Y1 | Quiz 2 | Quiz | 5% | In-class short quiz (5-7 questions; MCQ and short answer) worth 5%, administered during Seminar 4. |
| PHARM 220 | Y1 | Final Exam | Final exam | 40% | Cumulative OSCE-format final exam with interactive and non-interactive stations; drug information resources allowed. |
| PHARM 220 | Y1 | Professionalism | Participation/professionalism | 5% | Individual professionalism grade (5%); starts at 5%, deductions for infractions; includes required self-assessments and possible accountability form. |
| PHARM 220 | Y1 | Lab Assignments, Quizzes & Reflections | Quiz | 55% | Various weekly/bi-weekly assignments, quizzes, reflections and simulated-patient tasks; individual and group assessments; weights 1-5% per activity. |
| PHARM 223 | Y1 | Critical Reflection | Assignment/written work | 5% | Two reflections: first formative (ungraded), second graded = 5% of course. |
| PHARM 223 | Y1 | Lab Assignments | Assignment/written work | 25% | Multiple pre-lab and in-lab activities (individual and group) totaling 25%; weights vary by activity; some completion-based. |
| PHARM 223 | Y1 | Final Exam | Final exam | 35% | Cumulative OSCE with interactive and non-interactive stations; both components on 2025-04-16. |
| PHARM 223 | Y1 | Midterm Exam | Midterm exam | 25% | OSCE with interactive and non-interactive stations; both components on 2025-02-27. |
| PHARM 223 | Y1 | Professionalism Mark | Participation/professionalism | 5% | 5% professionalism mark; infractions reduce mark; accountability form may be required. |
| PHARM 223 | Y1 | Medical Terminology | Quiz | 5% | 5x mandatory open-book eClass quizzes; each worth 1% upon ≥80% score, totaling 5%. |
| PHARM 320 | Y2 | Care Plan Assignment | Assignment/written work | 15% | Group two-part written care plan: initial submission (3 priorities) 5%, final submission 10%; rubric provided. |
| PHARM 320 | Y2 | Lab Activities | Assignment/written work | 40% | Application-based lab activities (role play, simulation, case-based) described in lab guides; details provided to students in lab guides. |
| PHARM 320 | Y2 | Final | Final exam | 40% | Final is OSCE-type with interactive and non-interactive stations assessing second-half objectives; scheduled for December 18, 2025. |
| PHARM 320 | Y2 | Professionalism Mark | Participation/professionalism | 5% | Individual professionalism assessment worth 5%; starts at 5% with deductions for infractions and possible Accountability Form. |
| PHARM 323 | Y2 | Integrated Cases | Assignment/written work | 10% | Group-based assessment of three patient cases over term; focuses on clinical decision-making and written communication. |
| PHARM 323 | Y2 | Lab Assignments | Assignment/written work | 25% | Multiple formative/summative lab activities (simulations, DI questions, quizzes, reflections) across term; most labs include a graded activity worth 2-5% each. |
| PHARM 323 | Y2 | Final Exam | Final exam | 35% | Final delivered as OSCE with interactive and non-interactive stations. |
| PHARM 323 | Y2 | Midterm | Midterm exam | 25% | Midterm delivered as OSCE with interactive and non-interactive stations. |
| PHARM 323 | Y2 | Professionalism | Participation/professionalism | 5% | Assessment of professional behaviours (preparation, reflections, participation). Starts at 5%; penalties of 0.5% or 1% for infractions; monitored by coordinators and facilitators. |
| PHARM 420 | Y3 | Care Planning Assignments | Assignment/written work | 20% | 20% total (two cases: Case 1 10% due Oct 27; Case 2 10% due Dec 2). Group-based case work with staged tasks; some components may be individual. |
| PHARM 420 | Y3 | Lab | Assignment/written work | 35% | 35% from various lab assignments/quizzes (weekly/bi-weekly); formats include quizzes, simulations, written drug-information tasks, reflections; individual and group assessments; activity weights 1-5%. |
| PHARM 420 | Y3 | Final OSCE | OSCE | 40% | 40% OSCE final exam; cumulative; multiple OSCE stations with direct patient care; may include topics from entire program. |
| PHARM 420 | Y3 | Professionalism | Participation/professionalism | 5% | Professionalism assessed out of 5% for pre-lab completion, seminar participation, lab participation/timely submission, lab management and professional behaviour. Infractions reduce mark by 0.5-1%; coordinator may require a Professionalism Accountability Form. |
| PHARM 423 | Y3 | Additional Prescribing Authority Preparedness Assignment | Assignment/written work | 15% | Individual reflective assignment using APA application questions; rubric provided. |
| PHARM 423 | Y3 | Lab Assignments | Assignment/written work | 20% | Application-based lab activities; specifics provided in lab guides prior to each lab. |
| PHARM 423 | Y3 | Written Assessment | Final exam | 20% | Final exam is cumulative and includes non-interactive (written) and interactive (OSCE) portions; non-interactive assesses written competencies. |
| PHARM 423 | Y3 | OSCE | OSCE | 40% | OSCE is the interactive portion of the cumulative final exam (stations involving patient care); date TBD. |
| PHARM 423 | Y3 | Professionalism | Participation/professionalism | 5% | Professionalism assessed via pre-lab completion, participation, timely submissions, lab management, and behaviour; infractions reduce mark (0.5-1% each); accountability form may be required. |
About this Evidence
Where did this information come from, and how was it prepared?
What information is included
This curriculum portrait brings together the curriculum records available for the selected stream and academic cycle. These include course information and learning outcomes, documented sessions and topics, assessment information, and links to the CCAPP and AFPC curriculum frameworks.
The amount of descriptive detail varies across academic cycles because the underlying source material is not identical. Current-cycle records are drawn largely from syllabus information, while some earlier-cycle records come from legacy curriculum data that contain less narrative detail. Missing information is left visible rather than filled in.
How topics are connected to curriculum frameworks
Documented curriculum topics are matched to CCAPP curriculum categories with OpenAI assistance. A topic can be matched to more than one CCAPP category when it clearly relates to more than one area.
CCAPP categories are linked to AFPC professional roles. Those links are used to show the AFPC role patterns in the curriculum portrait. These profiles describe where curriculum content is documented. They do not show instructional time, student achievement, or preparedness for practice.
How the charts and percentages are calculated
The values in the charts are calculated directly from the curriculum records. AI-generated text does not calculate these numbers. Each chart is based on a different type of evidence, so percentages from different charts should not be compared as though they use the same starting point.
- Learning outcomes
- Shows the share of classified learning outcomes identified as Knowledge, Skills or Attitudes.
- AFPC roles
- Shows the share of all curriculum links to AFPC professional roles.
- CCAPP topics
- Shows the share of all curriculum links to CCAPP topic categories. One documented topic can contribute to more than one category.
- Delivery
- Uses instructional hours when session-duration information is complete enough for comparison. Otherwise it shows the number of documented sessions.
- Assessment
- Uses assessment weight when comparable weighting information is complete enough. Otherwise it shows the number of documented assessments.
The year-by-year profiles are descriptive comparisons. A visible difference between years does not, by itself, mean that an educationally important change occurred.
How the written summaries are created
The written summaries are built in steps so that broad descriptions remain connected to the underlying curriculum records. Detailed session and assessment information is first organized into summaries for each stream and program year. Those summaries are then used to create the overall stream descriptions shown to reviewers.
AI-assisted writing is used to help produce concise reviewer-facing descriptions from these prepared evidence summaries. It does not calculate the charts or decide whether the curriculum is good, coherent, effective, or whether students have achieved the intended outcomes.
The written summaries are prepared before the report is displayed. Opening or browsing this report does not send a new request to an AI service.
How missing or incomplete information is shown
When the available records are incomplete, the report shows that limitation rather than making an assumption. Examples include missing session duration, incomplete assessment weighting, and older course or assessment records that do not contain the same descriptive detail as newer syllabus-derived records.
For relationships between streams, the same evidence rule is applied from either direction. If there is not enough information to describe a relationship for a particular year and cycle, both stream views show that limitation consistently.